{"title": "Richard Bucala", "author": "Richard Bucala", "url": "https://www.yalemedicine.org/specialists/richard-bucala", "hostname": "yalemedicine.org", "description": "Richard Bucala, MD, PhD, is a Professor of Medicine, Pathology, and Epidemiology & Public Health. He studies the mechanisms by which protective immune responses lead to immunopathology, focusing on MIF-family cytokines and their genetics, which his group first cloned and characterized experimentally. Currently, his laboratory is leading multidisciplinary efforts to develop immunotherapies tailored to an individual's genetic makeup. An anti-MIF antibody developed by the group is undergoing clinical testing in oncology, and an anti-MIF receptor antibody, recently FDA approved, is under evaluation in SLE. Dr. Bucala also is credited with the discovery of the fibrocyte, which is being targeted therapeutically in different fibrosing disorders. He is a co-founder of Cytokine Networks and of MIFCOR, a biotechnology startup begun as a student-advised project. Dr. Bucala was elected to the American Society for Clinical Investigation and the Association of American Physicians. He is the Editor-in-Chief of Arthritis & Rheumatology and has served on numerous advisory boards for the NIH, the pharmaceutical industry, academia, and private foundations.", "sitename": "Yale Medicine", "date": "2023-08-28", "cleaned_text": "Richard Bucala, MD, PhD Biography Richard Bucala, MD, PhD, is a Professor of Medicine, Pathology, and Epidemiology & Public Health. He studies the mechanisms by which protective immune responses lead to immunopathology, focusing on MIF-family cytokines and their genetics, which his group first cloned and characterized experimentally. Currently, his laboratory is leading multidisciplinary efforts to develop immunotherapies tailored to an individual's genetic makeup. An anti-MIF antibody developed by the group is undergoing clinical testing in oncology, and an anti-MIF receptor antibody, recently FDA approved, is under evaluation in SLE. Dr. Bucala also is credited with the discovery of the fibrocyte, which is being targeted therapeutically in different fibrosing disorders. He is a co-founder of Cytokine Networks and of MIFCOR, a biotechnology startup begun as a student-advised project. Dr. Bucala was elected to the American Society for Clinical Investigation and the Association of American Physicians. He is the Editor-in-Chief of Arthritis & Rheumatology and has served on numerous advisory boards for the NIH, the pharmaceutical industry, academia, and private foundations. Titles - Waldemar Von Zedtwitz Professor of Medicine (Rheumatology) and Professor of Pathology and of Epidemiology (Microbial Diseases) - Chief, Rheumatology, Allergy, & Immunology - Rheumatologist in Chief, Rheumatology - Affiliated Faculty, Yale Institute for Global Health Education & Training - FellowHospital for Special Surgery (1991) - ResidentBrigham & Women's Hospital/Harvard Medical School (1988) - MDCornell College (1986) - PhDRockefeller University (1985) - Visiting FellowInstitut Pasteur, Paris (1985) - BSYale University (1979) - MSYale University (1979) Additional Information - American Association of Physicians: (2009) - American Society for Clinical Investigation: (1996) - Arthritis & Rheumatology (2015 - Present): Editor-in-Chief - Journal of Immunology (2010 - 2015): Associate Editor - Alumni Schools Committee (2008 - 2012): Member - NIH (2006 - 2012): NIH Biodefense and Chemical Countermeasures - Shin JJ, Fan W, Par-Young J, Piecychna M, Leng L, Israni-Winger K, Qing H, Gu J, Zhao H, Schulz WL, Unlu S, Kuster J, Young G, Liu J, Ko AI, Garcia A, Sauler M, Wisnewski AV, Young L, Ordu\u00f1a A, Wang A, Klementina O, Garcia AB, Hegyi P, Armstrong ME, Mitchell P, Ordiz DB, Garami A, Kang I, Bucala R. MIF is a Common Genetic Determinant of COVID-19 Wang W, Zalavadia A, Makarav V, Troike K, McGraw M, Rabljenovic A, Lauko A, Neumann C, Roversi G, Waite N, Tran T, McCortney K, Steffens A, Diaz-Montero C, Brown J, Egan K, Horbinski C, Barnholtz-Sloan J, Rajappa P, Vogelbaum M, Bucala T, Ahluwalia M, Lathia J. The SNP rs755622 is associated with glioblastoma. JCI 2023 [PMID: 37252795](https://pubmed.ncbi.nlm.nih.gov/37252795), [DOI: 10.1172/jci.insight.160024](https://doi.org/10.1172/jci.insight.160024). - Ye Mahmood D, Leng L, Bucala R, Vera P. Urothelial Oxidative Stress and ERK Activation 2023, 12: 1440. [PMCID: PMC10217556](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217556), [DOI: 10.3390/cells12101440](https://doi.org/10.3390/cells12101440). - Huang Y, Cui D, Chen L, Tong H, Wu H, Muller G, Qi Y, Wang S, Xu J, Gao X, Fifield K, Wang L, Xia Z, Vanderluit J, Liu S, Leng L, Sun G, McGuire J, Young L, Bucala R, Qi D. A pref-1-controlled non-inflammatory mechanism PMC10239698](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239698), [DOI: 10.1016/j.isci.2023.106923](https://doi.org/10.1016/j.isci.2023.106923). - Huang Y, Cui D, Chen L, Tong H, Wu H, Muller G, Qi Y, Wang S, Xu J, Gao X, Fifield K, Wang L, Xia Z, Vanderluit J, Liu S, Leng L, Sun G, McGuire J, Young L, Bucala R, Qi D. A pref-1-controlled non-inflammatory mechanism Anniversary of The Journal of Rheumatology: The Past, Present, and Future of Rheumatology](http://www.ncbi.nlm.nih.gov/pubmed/36587952)Masi A, Bucala R. Reflections for the 50th Anniversary of The Journal of Rheumatology: The Past, Present, and Future of Rheumatology The malaria vaccine 2023 [DOI: 10.33424/futurum362](https://doi.org/10.33424/futurum362). [Correction to: Clinical features and high-risk indicators of central nervous system involvement in primary Sj\u00f6gren's syndrome](http://www.ncbi.nlm.nih.gov/pubmed/36565380)Fan W, Par-Young J, Li K, Zhang Y, Xiao P, Hua L, Leng L, Chen X, Bucala R. Correction to: Clinical features and high-risk indicators of central nervous system involvement in primary Sj\u00f6gren's of central nervous system involvement in primary Sj\u00f6gren's syndrome](http://www.ncbi.nlm.nih.gov/pubmed/36401063)Fan W, Par-Young J, Li K, Zhang Y, Xiao P, Hua L, Leng L, Chen X, Bucala R. Clinical features and high-risk indicators of central nervous system involvement in primary Sj\u00f6gren's Radomir L, Lewinsky H, Leng L, Bucala R, Becker-Herman S, Shachar I. CD74 as a regulator of transcription in normal B cells Reports Increased Proportions of the Highly Permissive Th17-like Cell Profile during HIV Infection](http://www.ncbi.nlm.nih.gov/pubmed/36298774)Trifone C, Baquero L, Czernikier A, Benencio P, Leng L, Laufer N, Quiroga MF, Bucala R, Ghiglione Y, Turk G. Macrophage Migration Inhibitory Factor (MIF) Promotes Increased Proportions of the Highly Permissive Th17-like Cell Profile during HIV Poor Immune Responses to COVID-19 mRNA Vaccines in Patients with Primary Antibody Deficiency](http://www.ncbi.nlm.nih.gov/pubmed/35713752)Shin JJ, Par-Young J, Unlu S, McNamara A, Park HJ, Shin MS, Gee RJ, Doyle H, Afinogenova Y, Zidan E, Kwah J, Russo A, Mamula M, Hsu FI, Catanzaro J, Racke M, Bucala R, Wilen C, Kang I. Defining Clinical and Immunological Predictors of Poor Immune Responses to COVID-19 mRNA Vaccines in Patients with Primary Antibody Deficiency Journal acute EAE in MIF-1-deficient female and male mice with a bifunctional MHCII-derived molecular construct](http://www.ncbi.nlm.nih.gov/pubmed/35738135)Vandenbark AA, Meza-Romero R, Wiedrick J, Gerstner Seifert H, Kent G, M, Benedek G, Bucala R, Offner H. \"Near Cure\" treatment of severe acute EAE in MIF-1-deficient female and male mice with a bifunctional Leng L, Bucala R, Vera Oxidative Stress and HMGB1 Release Contribute to PAR4-Mediated Bladder Pain in Mice Signaling Axis in Alveolar Type II Epithelial Cells](https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2323)Kim S, Yang T, Peng X, Leng L, Bucala R, Lee P, Herzog E, Sauler M. Profibrotic Role for a Dysregulated D-Dopachrome Tautomerase-Cullin 3 Signaling Axis Alveolar Type II Epithelial Cells 2022, a2323-a2323. [DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2323](https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2323). - Yang T, Kim S, Leng L, Nouws J, Bucala R, Sauler M. The OXIDATIVE STRESS AND ERK SIGNALING CONTRIBUTE TO BLADDER PAIN MEDIATED BY MACROPHAGE MIGRATION INHIBITORY FACTOR AND HIGH MOBILITY GROUP BOX 1](https://doi.org/10.1097/ju.0000000000002529.05)Ye S, Ma F, Mahmood D, Meyer-Siegler K, Leng L, Bucala R, Vera P. MP07-05 BLADDER OXIDATIVE STRESS AND ERK SIGNALING CONTRIBUTE TO BLADDER PAIN MEDIATED BY MACROPHAGE MIGRATION INHIBITORY FACTOR AND HIGH MOBILITY GROUP BOX RP, Mostafavi H, Tang PCH, Bucala R, Teixeira MM, Taylor A, Zaid A, innate immune sensor responses in gingival epithelial cells](http://www.ncbi.nlm.nih.gov/pubmed/35100435)Kantrong N, Chang AM, Bamashmous RJ, Darveau RP. Macrophage migration inhibitory factor regulates specific innate immune sensor responses in gingival epithelial cells decrease stress, disease activity, and inflammatory cytokine levels in patients with autoimmune hepatitis](http://www.ncbi.nlm.nih.gov/pubmed/35434588)Alrabadi LS, Dutton A, Rabiee A, Roberts SJ, Deng L, JL, Assis DN. Mindfulness-based stress reduction may decrease stress, disease activity, and inflammatory cytokine levels in patients with autoimmune hepatitis autoimmunity Proceedings Of The National Academy Of Sciences Of The United States Of remodeling and contractile dysfunction through pyroptosis-evoked regulation of ferroptosis](http://www.ncbi.nlm.nih.gov/pubmed/35033649)Chen L, Yin Z, Qin X, Zhu X, Chen X, Ding G, Sun D, Wu NN, Fei J, Bi Y, Zhang J, Bucala R, Ren J, Zheng Q. CD74 ablation rescues type 2 diabetes mellitus-induced cardiac remodeling and contractile dysfunction through Receptors Are Differentially Expressed in Rheumatoid Arthritis Patients Evaluated by DAS28-ESR](http://www.ncbi.nlm.nih.gov/pubmed/35011861)S\u00e1nchez-Zuno GA, Bucala R, Hern\u00e1ndez-Bello Rom\u00e1n-Fern\u00e1ndez Receptors Are Differentially Expressed in Rheumatoid Arthritis Patients Evaluated by DAS28-ESR Journal X, Bucala R, Lewandowski LB, Hsieh E. Global Rheumatology J, Sauler M, Piecychna M, Pantouris G, Lolis L, J, Fingerle-Rowson G, Bucala R. MIF but not MIF-2 recruits inflammatory macrophages in an experimental polymicrobial sepsis model Brandt E, Koenen M, Djudjaj S, Schneider at the MIF Immune Susceptibility Locus](http://www.ncbi.nlm.nih.gov/pubmed/33844457)Yao J, Leng L, Fu W, Li J, Bronner C, Bucala R. ICBP90 Regulates MIF Expression, Glucocorticoid Sensitivity, and Apoptosis Mahmood D, Meyer-Siegler K, Menard R, Hunt D, Leng L, Bucala R, Vera P. MP08-05 BLADDER MACROPHAGE MIGRATION INHIBITORY F, Mahmood DFD, Meyer-Siegler KL, Menard CD74 and CXCR4, Inhibitory Factor (MIF) Contributes to Adipocyte Hypertrophy and Development of Obesity](https://doi.org/10.2337/db21-197-lb)CHEN L, HUANG Y, LI L, ZABIHI H, QI Y, LENG L, SUN G, BUCALA R, QI D. 197-LB: The Regulation of HSL by Macrophage Migration Inhibitory Factor (MIF) Contributes to Adipocyte Hypertrophy and Development of Price CC, V, Kaman K, Davis M, Chupp G, Bucala R, Kaminski N, Topal JE, Dela Cruz patients with alcohol-associated hepatitis](http://www.ncbi.nlm.nih.gov/pubmed/33945507)Poulsen KL, Fan X, Kibler CD, Huang E, Wu X, McMullen MR, Leng L, Bucala R, Ventura-Cots M, Argemi J, Bataller R, Nagy LE. Role of MIF in coordinated expression of hepatic chemokines in aging UMHET3 male mice; nicotinamide riboside and three other drugs do not affect lifespan in either sex](http://www.ncbi.nlm.nih.gov/pubmed/33788371)Harrison DE, Strong R, Reifsnyder P, Kumar N, Fernandez E, Flurkey K, Javors A, Bitto A, Sindler AL, Cortopassi G, Kavanagh K, Leng L, Bucala R, Rosenthal N, Salmon A, Stearns TM, Bogue M, Miller RA. 17aestradiol late in life extends lifespan in aging UMHET3 male mice; nicotinamide riboside and three other drugs do not affect lifespan in either sex Aging C, Gil-Yarom N, Kramer M, Barak A, Sever L, David K, Radomir L, Lewinsky H, Levi M, Friedlander G, Bucala R, Peled A, Shachar I. CD74 is a regulator colorectal cancer](http://www.ncbi.nlm.nih.gov/pubmed/33542244)Klemke L, via macrophage recruitment and angiogenesis in colorectal cancer Cell Is Linked to a Shift in NKT Cell Populations](http://www.ncbi.nlm.nih.gov/pubmed/33525493)Heinrichs D, Brandt EF, Fischer J, ML. Unexpected Pro-Fibrotic Effect of MIF in Non-Alcoholic Steatohepatitis Is Linked to a Shift in NKT Cell inhibitory predicts outcome in patients with acute decompensation of cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/33659891)Wirtz TH, Reuken PA, Jansen C, Fischer P, C, Emontzpohl C, Rei\u00dfing T, ML. Balance between macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cell abnormalities in mice\" [Leuk. Res. 96C (2020) 106428]](http://www.ncbi.nlm.nih.gov/pubmed/33288274)Liu T, Ahmed Shirai CL, Shao J, Nunley R, Bucala A, M, Walter MJ. Corrigendum to \"Haploinsufficiency of multiple del(5q) genes induce B cell abnormalities in mice\" [Leuk. Res. receptor that blocks atherogenic inflammation by agonist-specific targeting](http://www.ncbi.nlm.nih.gov/pubmed/33239628)Kontos C, El Bounkari O, Krammer C, Sinitski D, Hille K, Zan C, Yan G, Wang S, Gao Y, Brandhofer M, Megens RTA, Hoffmann A, Pauli J, Asare M, Weber C, Kapurniotu A, Bernhagen J. Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific [DOI: 10.1038/s41467-020-19764-z](https://doi.org/10.1038/s41467-020-19764-z). Pfau D, Wu X, Rao V, Testani J, Margulies K, Bucala R, Young L. 14834: Protective Role of Cardiomyocyte-derived Ddt in Ischemic Cardiomyopathy Circulation 2020, 142 [DOI: 10.1161/circ.142.suppl_3.14834](https://doi.org/10.1161/circ.142.suppl_3.14834). - Kim S, Wan F, Zhang X, Zhang Y, Ifedigbo E, Leng L, Bucala R, Lee P, Sauler M. MIF-CD74 Signaling Protects Against Endothelial Senescence in Chronic Obstructive Pulmonary Disease 2020, a4374-a4374. [DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4374](https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4374). - Kim S, Wan F, Zhang X, Zhang Y, Ifedigbo E, Leng L, Bucala R, Sauler M, Lee P. MIFCD74 Signaling Protects against Endothelial Senescence in Chronic Obstructive Pulmonary The FASEB MEDIATES BLADDER PAIN](https://doi.org/10.1097/ju.0000000000000867.013)Ye Ma F, Meyer-Siegler K, Leng L, Bucala R, Vera* P. MP28-13 INTRAVESICAL MACROPHAGE FACTOR Urology 2020, 203 [DOI: 10.1097/ju.0000000000000867.013](https://doi.org/10.1097/ju.0000000000000867.013). [GENE-26. HOST GENETIC VARIATIONS IN MACROPHAGE MIGRATION INHIBITOR FACTOR CONFER WORSE PROGNOSIS IN GLIOBLASTOMA](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6847914)Otvos B, Grabowski M, Alban T, Golubovsky R, M, J. GENE-26. HOST GENETIC VARIATIONS IN MACROPHAGE MIGRATION INHIBITOR FACTOR CONFER GROWTH](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6847354)Alban TARGETING IMMUNOSUPPRESSIVE MYELOID SUPPRESSOR VIA May Contribute Disseminated Coccidioidomycosis Susceptibility](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810323)Odio C, Leng L, Siu E, Piecychna M, Galgiani J, Holland S, Bucala R. 2598. Macrophage Migration Inhibitory Factor May Contribute to Disseminated Coccidioidomycosis Susceptibility Open Forum Infectious Diseases 2019, 6: s903-s903. [DOI: 10.1093/ofid/ofz360.2276](https://doi.org/10.1093/ofid/ofz360.2276). S. 830 Can CD74 Predict Treatment Response to Anti-TNF Agents in Inflammatory Bowel Disease? The American Induced Heart Failure](https://doi.org/10.1161/res.125.suppl_1.875)Ma Y, Hu X, Wu X, Pfau D, Leng L, Bedi K, Margulies K, Bucala R, Young L. Abstract 875: Cardiomyocyte Derived DDT Protects Against Myocardial Infarction Induced Heart Failure Circulation Research 2019, 125 [DOI: 10.1161/res.125.suppl_1.875](https://doi.org/10.1161/res.125.suppl_1.875). - Ardito T, Nouws J, Kim S, Zhang Y, Bucala R, Lee P, Sauler M. Protective Role of D-Dopachrome Tautomerase (MIF2) in Chronic Obstructive Pulmonary Disease 2019, a5374-a5374. [DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5374](https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5374). - Tilstam P, Schulte W, Holowka T, Kim B, Piecychna M, Pantouris G, Lolis E, Leng L, Bernhagen J, Bucala R. Selective Recruitment of Lethal Pro-inflammatory Macrophages in Sepsis by MIF but not Of MIF and MIF2 have distinct but synergistic roles in CIA The Journal Of Immunology 2019, 180.13-180.13. Schulte W, Maerz L, Moeckel G, Bucala R. Chapter 83 Adaptive Immunity and Critical Illness 2019, 483-487. [DOI: 10.1016/b978-0-323-44942-7.00083-2](https://doi.org/10.1016/b978-0-323-44942-7.00083-2). - Hannan MT, Bucala R. A Fresh New Look, and a Fresh New Journal Arthritis Care & Research 2018, 71: associated with reduced diffusing capacity](http://www.ncbi.nlm.nih.gov/pubmed/30520689)Zhang C, Ramsey C, Berical A, Yu L, Leng L, McGinnis K, Song Y, Michael H, McCormack M, Allore H, Morris A, Crothers K, Bucala R, Lee P, Sauler M. A functional macrophage migration inhibitory factor promoter polymorphism is associated with reduced diffusing capacity American Journal Of Physiology - Lung Cellular And Molecular Physiology in Sepsis by Macrophage Migration Inhibitory Factor But Its Homologue MIF2](https://doi.org/10.1016/j.jamcollsurg.2018.07.118)Schulte W, Tilstam P, Holowka T, Piecychna M, Leng L, Bernhagen J, Bucala R. Selective Recruitment of a Lethal Macrophage Subset in Sepsis by Macrophage Migration Inhibitory Factor But Not Its Homologue MIF2 Journal Of The American College Of [DOI: 10.1016/j.jamcollsurg.2018.07.118](https://doi.org/10.1016/j.jamcollsurg.2018.07.118). muscle cells exerts atheroprotective European Heart Journal 2018, 39 [DOI: 10.1093/eurheartj/ehy563.4148](https://doi.org/10.1093/eurheartj/ehy563.4148). - Pantouris G, Ho J, Shah D, Syed M, Leng L, Bhandari V, Bucala R, Batista V, Loria J, Lolis E. Dynamics Chemie 2018, 130: 7234-7237. Bucala R, Meyer-Siegler K, Vera P. PD55-03 PAR4 ACTIVATION AS A PERSISTENT MODEL OF BLADDER PAIN: ROLE OF MIF inhibitory factor in non-alcoholic steatohepatitis is associated with a shift in natural killer T cell populations](https://doi.org/10.1016/s0168-8278(18)31017-1)Heinrichs D, Brandt E, Fischer P, Koehncke J, Wirtz T, Djudjaj S, Boor P, Bucala C, J, M. FRI-068 Novel properties of macrophage migration inhibitory factor in non-alcoholic steatohepatitis is associated with a shift in natural killer T cell populations Journal Of Hepatology 2018, 68: s392. [DOI: 10.1016/s0168-8278(18)31017-1](https://doi.org/10.1016/s0168-8278(18)31017-1). [PS-083 Protection from Gao-Binge induced liver injury in Mif-/- Mice is associated with decreased ER stress](https://doi.org/10.1016/s0168-8278(18)30313-1)Poulsen K, Mcmullen M, Sheehan M, Leng L, Bucala R, Nagy L. PS-083 Protection from Gao-Binge induced liver injury in Mif-/- Mice is associated with decreased ER stress Journal Of Hepatology 2018, 68: s47-s48. receptor (CD74+) expressing memory T cell subpopulation is sufficient to transfer inflammatory arthritis](https://doi.org/10.4049/jimmunol.198.supp.156.3)Doherty E, Piecychna M, Leng L, Bucala R. Adoptive transfer of a novel MIF receptor (CD74+) expressing memory T cell subpopulation is sufficient to transfer inflammatory arthritis The Journal 2017, 198: 156.3-156.3. [DOI: 10.4049/jimmunol.198.supp.156.3](https://doi.org/10.4049/jimmunol.198.supp.156.3). [Macrophage an Upstream Regulator of NLRP3 Expression and Subsequent IL-1beta Production in Human Monocytes in Response to Lupus U1-snRNP Immune Complex](https://doi.org/10.4049/jimmunol.198.supp.210.3)Shin M, Kang Y, Leng L, Bucala R, Kang I. Macrophage Migration Inhibitory Factor Serves As an Upstream Regulator of NLRP3 Expression and Subsequent IL-1beta Production in Human Monocytes in Response to Lupus U1-snRNP hepatic inflammation in a model of autoimmune liver disease](https://doi.org/10.1016/s0168-8278(17)31067-x)Roberts S, Leng L, Soroka C, Boyer J, Bucala T-cell proliferation and hepatic inflammation in a model of autoimmune liver disease Journal Of Hepatology 2017, F. CD74-dysregulation of placental Patients Exhibited A, Kraemer S, Emontzpohl C, J, Bucala R, Weber C, Bernhagen J. Abstract 16602: The Clinical Significance of Mif, Mif-2 and Mif Genotype in Patients Exhibited [DOI: F, R, Herse F. 042: Cd74-dysregulation of 66 [DOI: 10.1161/hyp.66.suppl_1.042](https://doi.org/10.1161/hyp.66.suppl_1.042). - Bucala R. SP0184 Selecting the Best Journal for Communicating Research Findings Annals Of The Rheumatic Diseases 2015, 74: 45. [DOI: 10.1136/annrheumdis-2015-eular.6820](https://doi.org/10.1136/annrheumdis-2015-eular.6820). - Das R, Larose M, Hergott Leng Bucala R, Weiser J. 1677Macrophage migration inhibitory factor (MIF) promotes clearance of pneumococcal colonization Open Forum Diseases 1: s448-s448. [PMCID: PMC5782292](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782292), [DOI: 10.1093/ofid/ofu052.1223](https://doi.org/10.1093/ofid/ofu052.1223). leukocyte derived macrophage migration inhibitory factor in inflammatory responses remodelling myocardial infarction' [J Mol Cell Kanellakis P, Kiriazis H, Morand E, Bucala R, Dart A, Du X, Gao X. Erratum to 'Differential roles of cardiac and leukocyte derived macrophage migration inhibitory factor in inflammatory responses remodelling myocardial infarction' [J Mol Cell Cardiol 69 Cellular Cardiology 2014, 75: 198. [DOI: 10.1016/j.yjmcc.2014.08.005](https://doi.org/10.1016/j.yjmcc.2014.08.005). - Blakaj A, Chi X, Mourad W, Herzog E, Leng L, Bucala R. Metallothioneins in Fibrosis: Implications for Radiation-Induced Fibrosis International Oncology Biology Physics 2014, 90: s684-s685. [DOI: 10.1016/j.ijrobp.2014.05.2011](https://doi.org/10.1016/j.ijrobp.2014.05.2011). - Greene M, Roland A, Pritzker L, Carlson C, Bucala R, Miller R, Loeser R. Deletion of macrophage migration inhibitory factor reduces severity of osteoarthritis in mice Osteoarthritis And Cartilage 2014, 22: s58-s59. [DOI: 10.1016/j.joca.2014.02.122](https://doi.org/10.1016/j.joca.2014.02.122). - Sun T, Bucala R. The Scientific and Medical Challenge of Malaria 2014, 189-215. [DOI: 10.1142/9789814405584_0008](https://doi.org/10.1142/9789814405584_0008). - Montgomery R, Bucala R, Bockenstedt L. Memoriam: Stephen E. I, Kay S, Aloshin A, Sagi I, Goldenberg D, Leng L, Bucala R, Herishanu Y, Haran M, Shachar I. CD84 is a survival receptor for chronic lymphocytic leukemia cells (P2044) The Journal Of Immunology 2013, 190: 132.12-132.12. [DOI: 10.4049/jimmunol.190.supp.132.12](https://doi.org/10.4049/jimmunol.190.supp.132.12). - Benedek G, Meza-Romero Andrew Leng L, Burrows G, Bourdette D, Offner H, Bucala R, Vandenbark A. Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effects (P5221) The Journal 190: 67.4-67.4. lupus erythematosus and prospects for therapeutic intervention](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467510)Bucala R. Role of MIF gene polymorphisms in systemic lupus erythematosus and prospects for therapeutic intervention Arthritis Research 2012, 14: a33. [PMCID: using a knockout mouse approach](https://doi.org/10.1016/j.bbi.2012.07.064)Bay-Richter C, Janelidze S, Bucala R, Deierborg T, Brundin L. 40. Antidepressant effects of macrophage migration inhibitory factor using a knockout mouse approach Brain Behavior And Immunity 2012, 26: s11-s12. [DOI: 10.1016/j.bbi.2012.07.064](https://doi.org/10.1016/j.bbi.2012.07.064). - Bucala R. MIF, MIF the Host Response 2012, 3-22. [DOI: 10.1142/9789814335362_0001](https://doi.org/10.1142/9789814335362_0001). [1240 A FUNCTIONAL ROLE OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) FOR FATTY LIVER DISEASE AND OBESITY IN MICE](https://doi.org/10.1016/s0168-8278(12)61252-5)Heinrichs D, Knauel M, Nellen A, Trautwein C, Bucala R, J, H. A ROLE OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) FOR FATTY LIVER DISEASE AND OBESITY IN Journal Of Hepatology 2012, 56: s491. [DOI: Factor (MIF) for liver steatosis in mice by activation of AMP kinase](https://doi.org/10.1055/s-0031-1295805)Heinrichs D, Knauel M, Nellen A, Schmitz P, Trautwein C, Bucala R, Bernhagen J, Wasmuth H. A functional role of Macrophage Migration Inhibitory Factor (MIF) for liver steatosis in mice by activation AMP Zeitschrift 2012, Receptor Tyrosine Phosphatase Zeta Regulate B Cell Survival in Health and Disease in a Pathway Induced by CD74](https://doi.org/10.1016/j.clml.2011.09.024)Cohen S, Shoshana O, Zelman-Toister E, Maharshak N, Ehrenreich I, Gordin M, Shvidel L, Haran M, Leng L, Bucala R, Harroch S, Shachar I. 1.23 The Cytokine Midkine and its Receptor Tyrosine Phosphatase Zeta Regulate B Cell Survival in Health and Disease in a Pathway Induced by CD74 Clinical Lymphoma IN EXPERIMENTAL LIVER FIBROSIS VIA CD74 AND AMPK](https://doi.org/10.1016/s0168-8278(11)61040-4)Heinrichs Jung M, Offermanns C, Berres M, Nellen A, Schmitz P, Leng L, Bucala R, C, C, J, Wasmuth H. INHIBITORY FACTOR IN EXPERIMENTAL LIVER FIBROSIS Schmitz P, Bucala R, J, H. Systemic Fibrosis R. Abstract: TISSUE AND IMPAIRS INSULIN RESISTANCE AND ASSOCIATED ATHEROSCLEROSIS IN A MODEL OF COMBINED DISEASE](https://doi.org/10.1016/s1567-5688(10)70148-3)Kleemann R, Verschuren L, Wielinga P, Voshol P, van Erk M, Fingerle-Rowson G, van Dijk K, M, Bernhagen J, Bucala Kooistra T. MIF-DEFICIENCY REDUCES CHRONIC INFLAMMATION IN ADIPOSE TISSUE AND IMPAIRS INSULIN RESISTANCE AND ASSOCIATED ATHEROSCLEROSIS IN A MODEL OF COMBINED DISEASE Atherosclerosis Plus 2010, 11: 33. [DOI: 10.1016/s1567-5688(10)70148-3](https://doi.org/10.1016/s1567-5688(10)70148-3). [AV411 Vermeire L, Du X, Hodsdon M, Bucala R, Cappello M, Gross M, Gaeta F, Johnson K, Lolis E. AV411 (Ibudilast) and AV1013 are non-competitive a induced-fit infection](https://doi.org/10.1016/j.cyto.2009.07.571)Bosschaerts Morias Y, Engel D, Tacke F, Richard B, VandenDriessche T, Chuah M, De Baetselier P, Beschin A. Differentiation, activation and function of CD11b+Ly6C+ TNF/iNOS-producing dendritic [MRI in the era of nephrogenic systemic fibrosis: Review, controversies and suggestions for risk reduction](https://doi.org/10.37549/ar1683)Kuo P, Abu-Alfa A, Bucala R, Griffith J, Carlson K, Girardi M, Weinreb J, Cowper S. MRI in the era of nephrogenic systemic fibrosis: Review, controversies and suggestions for risk reduction Applied Radiology 2009, 22-33. [DOI: 10.37549/ar1683](https://doi.org/10.37549/ar1683). [MACROPHAGE MIGRATION INHIBITORY FACTOR ANTI-THROMBIN III COMPLEXES ARE DECREASED IN BLADDER CANCER PATIENT SERUM: COMPLEX FORMATION AS A POSSIBLE MECHANISM OF MIF INACTIVATION](https://doi.org/10.1016/s0022-5347(09)60867-3)Meyer-Siegler K, Cox J, Leng L, Bucala R, Vera P. MACROPHAGE MIGRATION INHIBITORY FACTOR ANTI-THROMBIN III COMPLEXES ARE DECREASED IN BLADDER CANCER PATIENT SERUM: COMPLEX FORMATION AS A POSSIBLE MECHANISM OF MIF INACTIVATION Investigative Urology 2009, 181: 304. Bucala R. Macrophage migration inhibitory factor and multiple organ dysfunction syndrome Journal Of Organ Dysfunction 2009, 5: 10-16. [DOI: 10.1080/17471060802443653](https://doi.org/10.1080/17471060802443653). - Doernberg S, Bucala R. CHAPTER 151 The Macrophage in Innate and Adaptive Immunity 2009, 784-788. [DOI: 10.1016/b978-1-4160-4252-5.50158-1](https://doi.org/10.1016/b978-1-4160-4252-5.50158-1). - Fg B, Dj N, Nm I, R, Metz C, Jp D, Atkins R. URINARY macrophage migration inhibitory factor (MIF) LEVELS REFLECT RENAL 2008, 5: a95-a95. [DOI: 10.1046/j.1440-1797.2000.abs26.x](https://doi.org/10.1046/j.1440-1797.2000.abs26.x). [URINE MIF BETWEEN HUMAN RENAL ALLOGRAFT REJECTION AND CYCLOSPORINE NEPHROTOXICITY](https://doi.org/10.1046/j.1440-1797.2000.abs41.x)Fg B, Dj N, Sj C, Cn M, Bucala R, Jp D, Atkins R. URINE MIF LEVELS DISCRIMINATE BETWEEN HUMAN RENAL ALLOGRAFT REJECTION AND [350: as a Target in Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation](https://doi.org/10.1016/j.bbmt.2007.12.360)Chang Y, Miklos S, Mueller G, Holler E, Lindner P, Leng L, Schubert T, Bucala R, Hildebrandt G. 350: Macrophage Migration Inhibitory Factor as a New Target in Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation Transplantation And Cellular Therapy 2008, 14: 128. [DOI: 10.1016/j.bbmt.2007.12.360](https://doi.org/10.1016/j.bbmt.2007.12.360). - Miklos S, Mueller G, Lindner P, Chang Y, Holler E, Bucala R, Hildebrandt G. Neutralization of Macrophage Migration Inhibitory Factor (MIF) Reduces 3234-3234. [DOI: 10.1182/blood.v110.11.3234.3234](https://doi.org/10.1182/blood.v110.11.3234.3234). - Quan T, Bucala R. Circulating Fibrocytes (MIF) Gene Polymorphisms are Associated with Susceptibility and Severity of Prostate Cancer](https://doi.org/10.1016/s0022-5347(18)31810-x)Meyer-Siegler K, Vera P, Iczkowski K, Bifulco C, Lee A, P, L, Bucala R. 1622: Macrophage Migration Inhibitory Factor (MIF) Gene Polymorphisms are Associated with Susceptibility and Severity of Prostate Cancer Investigative Urology 2007, 177: 537-538. [DOI: 10.1016/s0022-5347(18)31810-x](https://doi.org/10.1016/s0022-5347(18)31810-x). - Bucala Macrophage Migration Inhibitory Factor (MIF) Genetic Polymorphisms in Predicting the Development of Macrocytic Anemia in HIV+ Patients.](https://doi.org/10.1182/blood.v108.11.1254.1254)Lin S, Fultz S, Justice A, Bucala R, Vanasse K, Berliner N. The Role of Macrophage Migration Inhibitory Factor (MIF) Genetic Polymorphisms in Predicting the Development of Macrocytic Anemia in HIV+ Patients. Blood 2006, 108: 1254-1254. - Moss J, Metz in Cancer 2006 [DOI: 10.1002/3527600906.mcb.200400129](https://doi.org/10.1002/3527600906.mcb.200400129). - Bucala R. MIF and the Genetic Basis of Macrophage Responsiveness Current Immunology Reviews 2006, 2: 217-223. [DOI: 10.2174/157339506778018569](https://doi.org/10.2174/157339506778018569). [634: Mice with a Null Mutation For Macrophage Migration Inhibitory Factor Have Lower Stage Tumors in a Mouse Model of Bladder Cancer](https://doi.org/10.1016/s0022-5347(18)32880-5)Taylor J, Kuchel G, Hegde P, Voznesensky K, Bucala R, Pilbeam C. 634: Mice with a Null Mutation For Macrophage Migration Inhibitory Factor Have Lower Stage Tumors in a Mouse Model of Bladder Cancer Investigative Urology 2006, 175: 204. [DOI: 10.1016/s0022-5347(18)32880-5](https://doi.org/10.1016/s0022-5347(18)32880-5). [Tu-P10:495 Serum level of soluble receptor for advanced glycation end products is associated with circulating advanced glycation end products in type 2 diabetes](https://doi.org/10.1016/s1567-5688(06)81196-7)Tan K, Chow W, Shiu S, Bucala R, Betteridge D. Tu-P10:495 Serum level of soluble receptor for advanced glycation end products is associated with circulating advanced glycation end products in type 2 diabetes Atherosclerosis Plus 2006, 294. [DOI: 10.1016/s1567-5688(06)81196-7](https://doi.org/10.1016/s1567-5688(06)81196-7). [141: Macrophage Migration Factor Mediates Smooth Muscle Death in Bladder Outlet Obstruction](https://doi.org/10.1016/s0022-5347(18)34406-9)Taylor J, Zhu Q, Sasso D, Pilbeam C, Leng L, R, Kuchel G. 141: Macrophage Migration Inhibitory Factor Mediates Smooth Muscle Death in Bladder Outlet Obstruction Investigative Urology 2005, 173: 38. [DOI: 10.1016/s0022-5347(18)34406-9](https://doi.org/10.1016/s0022-5347(18)34406-9). [1409: Further Evidence for an Association between Macrophage Migration Inhibitory Factor and Prostate Cancer](https://doi.org/10.1016/s0022-5347(18)35543-5)Meyer-Siegler K, Iczkowski K, Leng L, Bucala R, Vera P. 1409: Further Evidence for an Association between Macrophage Migration Inhibitory Factor and Prostate Cancer Investigative Urology 2005, 382. [DOI: 10.1016/s0022-5347(18)35543-5](https://doi.org/10.1016/s0022-5347(18)35543-5). - Papoulis A, Cerami Bucala R. Glucose-mediated DNA Damage and Mutations: In and Vivo 2005, 249-253. [DOI: 10.1533/9781845698393.4.249](https://doi.org/10.1533/9781845698393.4.249). - Al-Abed NOVEL CROSSLINK EXHIBITING IMMUNOLOGICAL WITH FORMED T. Advanced Glycosylation of LDL: Role in Oxidative Modification and Diabetic Complications 2005, 286-291. [DOI: 10.1533/9781845698393.4.286](https://doi.org/10.1533/9781845698393.4.286). - Panagiotopoulos S, O'Brien R, Cooper M, Jerums G, Bucala R. Aminoguanidine Decreases Atherosclerotic Plaque Formation in the Cholesterol-Fed Rabbit 2005, 426. [DOI: 10.1533/9781845698393.7.426a](https://doi.org/10.1533/9781845698393.7.426a). - Fingerle-Rowson inhibitory factor are elevated in Pima Indians compared to Caucasians and are associated with insulin resistance](http://www.ncbi.nlm.nih.gov/pubmed/12552367)Vozarova B, Metz C, Stefan N, Hanson R, Lindsay R, Bucala R, Bogardus C, Tataranni P. Plasma concentrations of macrophage migration inhibitory factor are elevated in Pima Indians compared to Caucasians and are associated with insulin resistance Diabetologia 2002, 45: 1739-1741. [PMID: 12552367](https://pubmed.ncbi.nlm.nih.gov/12552367), [DOI: 10.1007/s00125-002-0896-4](https://doi.org/10.1007/s00125-002-0896-4). - Bucala R. New research International Congress Series 2002, 1245: 113-117. [DOI: 10.1016/s0531-5131(02)00886-5](https://doi.org/10.1016/s0531-5131(02)00886-5). - Bucala 10.1007/0-306-46870-0_10](https://doi.org/10.1007/0-306-46870-0_10). [Structure activity studies of macrophage migration inhibitory show a functional role for cysteine residues](https://doi.org/10.1007/0-306-46862-x_170)Bernhagen J, Kleemann R, Kapurniotu A, Bucala R, Brunner H. Structure activity studies of macrophage migration inhibitory factor show a functional role for cysteine residues 2002, 5: 400-401. [DOI: 10.1007/0-306-46862-x_170](https://doi.org/10.1007/0-306-46862-x_170). [Identification Teichberg Voelter W, Bucala R. Identification of a minimal peptide sequence of islet amyloid polypeptide (IAPP) in rat](http://www.ncbi.nlm.nih.gov/pubmed/10540199)Brown, Metz, Bucala, Atkins, Lan. of macrophage migration inhibitory factor in acute renal allograft rejection in the rat Clinical & and Suppresses Adverse AGE-mediated Cellular Effects In Vitro: A Potential AGE Sequestration Therapy for Diabetic Nephropathy?](http://www.ncbi.nlm.nih.gov/pubmed/11788787)Zheng F, Cai W, Mitsuhashi T, Vlassara H, Bucala R. Enhances Endproducts Vivo and Suppresses Adverse AGE-mediated Cellular Effects In Vitro: A Potential AGE Sequestration Therapy for Diabetic Nephropathy? Y, Bucala R, Z. Immunological Detection of a cells and promote angiogenesis in vivo](http://www.ncbi.nlm.nih.gov/pubmed/11641248)Hartlapp I, Abe R, Saeed R, Peng T, Voelter W, Bucala R, Metz C. Fibrocytes induce an angiogenic in endothelial cells and an important mediator in the pathogenesis of gastric inflammation in rats](http://www.ncbi.nlm.nih.gov/pubmed/11522746)Huang X, Hui C, Chen Y, Chun B, Wong Y, Fung P, Metz C, Cho C, Hui W, Bucala R, Lam S, Lan H. Macrophage migration inhibitory factor is an important mediator in the pathogenesis of gastric inflammation in rats H, Lawson J, FitzGerald G, Manogue K, Bucala R. Characterization of a Novel Hemoglobin-Glutathione Adduct That Is Elevated in Diabetic Patients 11488984](https://pubmed.ncbi.nlm.nih.gov/11488984), 10.1046/j.1440-1711.2001.01024.x](https://doi.org/10.1046/j.1440-1711.2001.01024.x). - Abe R, Donnelly Peng T, Bucala R, Metz C. Peripheral Blood Fibrocytes: Differentiation Pathway and Migration to Wound Sites The Journal DIAGNOSTIC TOOL IN HUMAN RENAL ALLOGRAFT REJECTION1](http://www.ncbi.nlm.nih.gov/pubmed/11455258)Brown F, Nikolic-Paterson D, Chadban S, Dowling J, Jose M, Metz C, Bucala R, Atkins R. URINE MACROPHAGE MIGRATION INHIBITORY FACTOR CONCENTRATIONS AS A DIAGNOSTIC TOOL IN HUMAN RENAL REJECTION1 Transplantation 2001, 71: 1777-1783. [PMID: 11455258](https://pubmed.ncbi.nlm.nih.gov/11455258), R, Peng T, Sailors J, Bucala R, Metz C. Regulation of the CTL Response by Macrophage Migration Inhibitory Factor Factor as a Secretory Protein from Rat Epididymis: Evidences for Alternative Release and Transfer to Spermatozoa](http://www.ncbi.nlm.nih.gov/pubmed/11474125)Eickhoff R, Wilhelm B, Renneberg H, Wennemuth G, Bacher M, Linder D, Bucala R, Seitz J, Meinhardt A. Purification and Characterization of Macrophage Migration Inhibitory Factor as a Secretory Protein from Rat Epididymis: Evidences for Alternative Release and Transfer to Spermatozoa 10.1007/bf03401836](https://doi.org/10.1007/bf03401836). X, Chen Y, Huang X, Metz C, Bucala R, Lau C, Lan H. De Novo Expression of Macrophage Migration Inhibitory Factor in Atherogenesis in precursor cells and the pathogenesis of M, Y, of Glycation End-Products for Cultured Cortical F, Atsumi T, Calandra T, Metz C, B, T, Bucala R. The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle Journal 408: 146-147. [PMID: 11089953](https://pubmed.ncbi.nlm.nih.gov/11089953), [DOI: 10.1038/35041654](https://doi.org/10.1038/35041654). - Lan H, Yang Nikolic-Paterson D, Yu X, Mu W, Isbel N, Metz C, Bucala R, Atkins R. Expression of macrophage migration inhibitory factor in human properties of macrophage migration inhibitory factor 359-366. 11100884](https://pubmed.ncbi.nlm.nih.gov/11100884), 10.1006/scbi.2000.0328](https://doi.org/10.1006/scbi.2000.0328). - Kim Mazzali M, Tang D, Metz C, Bucala R, Kivlighn S, Johnson R, Lan H. Involvement of Macrophage Migration Inhibitory Factor (MIF) in Experimental Uric Bradshaw J, Sutton W, Kuller L, Bucala R, Anderson D, Mossman S, Villinger F, Haigwood N. Macaque bloodderived antigenpresenting cells elicit after Ingestion of Plasmodium chabaudi-Infected Erythrocytes: Possible Role in the Pathogenesis of Malarial Anemia](http://www.ncbi.nlm.nih.gov/pubmed/10722628)Martiney J, Sherry B, Metz C, Espinoza Ferrer Calandra T, Broxmeyer H, Bucala R. Macrophage Migration Inhibitory Factor Release by Macrophages after Ingestion of Plasmodium chabaudi-Infected Erythrocytes: Possible Role in the Pathogenesis of Malarial migration inhibitory factor by endogenous glucocorticoids in L, Heumann D, M\u00e4nnel D, Bucala R, Glauser M. Protection from septic shock by neutralization of macrophage migration inhibitory factor Are Produced from Short Chain Sugars and Dicarbonyl Compounds in vivo](http://www.ncbi.nlm.nih.gov/pubmed/10859028)Takeuchi M, Makita Z, Bucala R, Suzuki T, Koike Y. Immunological Evidence that Non-carboxymethyllysine Advanced Glycation End-products Are Produced from Short Chain Sugars and Dicarbonyl Compounds in vivo Factor (MIF): A Critical Neurohumoral Mediator Annals Of The New York Academy Of Sciences 2000, 917: 665-671. [PMID: 11268395](https://pubmed.ncbi.nlm.nih.gov/11268395), [DOI: 10.1111/j.1749-6632.2000.tb05432.x](https://doi.org/10.1111/j.1749-6632.2000.tb05432.x). [Structure of a Advanced Glycation End Product That Is Immunologically Cross-Reactive with Its Naturally Occurring Counterparts ](http://www.ncbi.nlm.nih.gov/pubmed/10639083)Al-Abed Y, Bucala R. Structure of a Synthetic Glucose Derived Advanced Glycation End Product That Is Immunologically Cross-Reactive with Its Naturally [PMID: 10639083](https://pubmed.ncbi.nlm.nih.gov/10639083), R. Peripheral blood fibrocytes with proinflammatory function and regulation by glucocorticoids](http://www.ncbi.nlm.nih.gov/pubmed/10446857)Leech M, Metz C, Hall P, Hutchinson P, Gianis K, Smith M, Weedon H, Holdsworth S, Bucala E. factor in rheumatoid arthritis: Evidence of proinflammatory function and of Methylglyoxal by the Nucleophilic Migration (MIF) ROLE IN CELL PROLIFERATION AND GLUCOCORTICOID ACTION*](http://www.ncbi.nlm.nih.gov/pubmed/10364264)Mitchell R, Metz C, Peng T, Migration (MIF) REGULATORY ROLE IN CELL PROLIFERATION AND GLUCOCORTICOID ACTION* Journal M, Bucala R, Al-Abed Y. A Polyhydroxylated AU-rich instability element: Role in tumor cell glycolysis and the Warburg effect](http://www.ncbi.nlm.nih.gov/pubmed/10077634)Chesney J, Mitchell R, Benigni F, Bacher M, Spiegel L, Al-Abed Y, Han J, Metz C, Bucala R. An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: Role in tumor cell glycolysis and the Warburg effect Proceedings Of The National Academy Of Sciences Of The United States Of America in the cardioprotective effect of ethanol](http://www.ncbi.nlm.nih.gov/pubmed/10051651)Al-Abed Y, Mitsuhashi T, Li H, Lawson J, FitzGerald G, Founds H, Donnelly T, Cerami A, Ulrich P, Bucala R. Inhibition of advanced glycation endproduct formation by acetaldehyde: Role in the cardioprotective effect of ethanol Proceedings Of The National Academy Of Sciences Of The United States Of America in Angiogenesis and the Growth of a Murine Lymphoma](http://www.ncbi.nlm.nih.gov/pubmed/10404515)Chesney J, Metz C, Bacher M, Peng T, Meinhardt A, Bucala R. An Essential Role for Macrophage Migration Inhibitory Factor (MIF) in Angiogenesis and the Growth of a with the Potential for Connective Tissue Targeting](http://www.ncbi.nlm.nih.gov/pubmed/10072447)Grab D, Lanners H, Martin L, Chesney J, Cai C, Adkisson H, Bucala R. Interaction of Borrelia burgdorferi with Peripheral Blood Fibrocytes, Antigen-Presenting Cells with the Potential for Connective Tissue Targeting MIF in the control of insulin secretion during stress](http://www.ncbi.nlm.nih.gov/pubmed/10398546)Waeber G, Calandra T, Bonny C, Bucala R. A role for the endocrine and proinflammatory mediator MIF in the control of insulin secretion during stress Diabetes/Metabolism migration inhibitory factor.](http://www.ncbi.nlm.nih.gov/pubmed/9826378)Pastrana S, Metz C, Bucala R, Schleimer R, Bickel C, Scott A. Filarial nematode parasites secrete a homologue of the human cytokine macrophage migration inhibitory is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria](http://www.ncbi.nlm.nih.gov/pubmed/9736745)Calandra T, Spiegel L, Metz C, Bucala R. Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria Proceedings Of The National Academy Of Sciences Of The United States Of America in the Lenses and Blood Vessels of Cigarette Smokers](http://www.ncbi.nlm.nih.gov/pubmed/9848076)Nicholl I, Stitt A, Moore J, Ritchie A, Archer D, Bucala R. Increased Levels of Advanced Glycation Endproducts in the Lenses and Blood Vessels of Cigarette Smokers Molecular Medicine 1998, 4: 594-601. the Adult Rat Testis: Examination of the of the Seminiferous R, Wreford N, Lan H, Atkins R, Hedger M. Local Regulation of Macrophage Subsets in the Adult Rat Testis: Examination of the Roles of the Seminiferous Tubules, Testosterone, and Macrophage-Migration of (CMG) as a guanine advanced glycation end product density lipoprotein receptor-binding site are modified by advanced glycation end products](http://www.ncbi.nlm.nih.gov/pubmed/9636203)Wang X, Bucala R, Milne R. Epitopes close to the apolipoprotein B low density lipoprotein receptor-binding site are modified by advanced glycation end products Proceedings Of The National Academy Of Sciences Of The United States Of America Macrophage Migration Inhibitory Factor (MIF): Role of MIF in Regulating Glucocorticoid Production](http://www.ncbi.nlm.nih.gov/pubmed/10780884)Yang N, Nikolic-Paterson D, Ng W, Metz C, Bacher M, Meinhardt A, Bucala R, Atkins R, Lan H. Reversal of Established Rat Crescentic Glomerulonephritis by Blockade of Macrophage Migration Inhibitory Factor (MIF): Potential Role of MIF in Regulating Glucocorticoid M, Keough K, Kim I, Bucala R, Adamis A. Advanced Glycation End Products Increase Retinal Vascular Endothelial Growth Factor Expression. 1998, 18: 491. [DOI: 10.1097/00006982-199805000-00030](https://doi.org/10.1097/00006982-199805000-00030). - Leech M, Metz Santos L, Peng T, Holdsworth S, Bucala R, Morand E. Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis Arthritis & Rheumatism 1998, Inhibitory Factor (MIF) Annals Of The New York Lateral Wang Motoneurons in Familial and F, Mu W, Metz C, Chesney J, Gemsa D, Donnelly T, Atkins R, Bucala R. MIF Expression in the Rat Brain: Implications for Neuronal Function Dubrovsky L, Mitchell R, Rich D, Ulrich P, Bucala R, Cerami A, Bukrinsky M. Role of cyclophilin A in the uptake of HIV-1 by macrophages and T lymphocytes Proceedings Of The National Academy Of Sciences Of The United States Of America factor: biological and structural features](http://www.ncbi.nlm.nih.gov/pubmed/9535548)Bernhagen J, Calandra T, Bucala R. Regulation of the immune response by macrophage migration inhibitory factor: biological and structural features Journal 151-161. [PMID: 24 Macrophage Migration Inhibitory Factor (MIF): A Critical Upstream Regulator of Acute and Chronic Inflammatory Responses](https://doi.org/10.1016/s0065-7743(08)61089-1)Rice G, Liittschwager K, Metz C, Bucala R. Chapter 24 Macrophage Migration Inhibitory Factor (MIF): A Critical Upstream Regulator of Acute and Chronic Inflammatory Responses 1998, 33: 243-252. [DOI: 10.1016/s0065-7743(08)61089-1](https://doi.org/10.1016/s0065-7743(08)61089-1). - Kapurniotu A, Bernhagen Y, Teichberg S, Frank R, Voelter W, Bucala R. Contribution of advanced glycosylation to the amyloidogenicity of Cooper M, Jerums G. Aminoguanidine has an anti-atherogenic A, Al-Abed Y, Vlassara H, Bucala R, Cerami A. Tobacco smoke is a source of toxic reactive glycation products Proceedings Of The National Academy Of Sciences Of The United States Of America Migration Inhibitory Factor ](http://www.ncbi.nlm.nih.gov/pubmed/9398265)Bendrat K, Al-Abed Callaway T, Metz C, Bucala R. Biochemical and Mutational Investigations the circulating glycation derivatives in uremia](http://www.ncbi.nlm.nih.gov/pubmed/9407512)Fishbane S, Bucala R, Pereira B, Founds H, Vlassara H. Reduction of plasma apolipoprotein-B by effective removal of circulating glycation derivatives in Advanced Glycation Endproduct Modified-DNA (AGE-DNA)](http://www.ncbi.nlm.nih.gov/pubmed/9407550)Pushkarsky T, Rourke L, Spiegel L, Seldin M, Bucala R. Molecular Characterization of a Mouse Genomic Element Mobilized by Advanced Glycation Endproduct glucocorticoid activity with a critical role in inflammatory disease](http://www.ncbi.nlm.nih.gov/pubmed/9430786)Donnelly S, Bucala R. Macrophage migration inhibitory factor: a regulator of glucocorticoid activity with a critical role in inflammatory disease Trends In Molecular Medicine 1997, 3: Atherosclerosis: Relationship to Tissue AGEs](http://www.ncbi.nlm.nih.gov/pubmed/9323713)Stitt A, He C, Friedman S, Scher L, Rossi P, Ong L, Founds H, Li Y, Bucala R, Vlassara H. Elevated in Sera of Euglycemic, Normolipidemic Patients with Atherosclerosis: Relationship to Tissue 9323713](https://pubmed.ncbi.nlm.nih.gov/9323713), [PMCID: PMC2230092](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2230092), (MIF) C, de Kretser D, Bucala R, Hedger M. A switch in the cellular localization of macrophage migration inhibitory factor (MIF) in rat testis after Fatty Acid Oxidation Products by potent antigen-presenting cell capable of priming naive T cells in situ](http://www.ncbi.nlm.nih.gov/pubmed/9177213)Chesney J, Bacher M, Bender A, Bucala R. The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ Proceedings Of The National Academy Of Sciences Of The United States Of America risk factor in diabetic nephropathy](http://www.ncbi.nlm.nih.gov/pubmed/9177242)Koschinsky T, He C, Mitsuhashi T, Bucala R, Liu C, Buenting C, Heitmann K, Vlassara H. Orally absorbed reactive glycation products (glycotoxins): An environmental risk factor in diabetic nephropathy Proceedings Of The National Academy Of Sciences Of The United States Of America migration A, M, Metz C, Nicod P, Bucala R. Insulin secretion is regulated by the glucose-dependent production of islet cell macrophage migration inhibitory factor Proceedings Of The National Academy Of Sciences Of The United States Of America Factor in Immunologically Induced Kidney Disease in the Rat](http://www.ncbi.nlm.nih.gov/pubmed/9126926)Lan H, Bacher M, Yang N, Mu W, Nikolic-Paterson D, Metz C, Meinhardt A, Bucala R, Atkins R. The Pathogenic Role of Macrophage Migration Inhibitory Factor in Immunologically Induced Kidney Disease in the Rat Journal Of Experimental 1997, and Advanced Glycation: Promotion, Progression, and Preventiona Annals Of The New York Academy Of Sciences 1997, 811: 115-129. [PMID: 9186590](https://pubmed.ncbi.nlm.nih.gov/9186590), [DOI: 10.1111/j.1749-6632.1997.tb51994.x](https://doi.org/10.1111/j.1749-6632.1997.tb51994.x). - Donnelly S, Haslett C, Reid P, Grant I, Wallace W, Metz C, Bruce L, Bucala R. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome Nature Medicine 1997, 3: 320-323. [PMID: 9055860](https://pubmed.ncbi.nlm.nih.gov/9055860), [DOI: 10.1038/nm0397-320](https://doi.org/10.1038/nm0397-320). - Lan H, Yang N, Metz C, Mu W, Song Q, Nikolic-Paterson D, Bacher M, Bucala R, Atkins R. TNF- Up-regulates Renal MIF Expression in Endproducts (AGEs): Role Inhibitory Factor (MIF): A Glucocorticoid Counter-Regulator within the of Macrophage Migration Inhibitory Factor in the Regulation of the MIF rediscovered: cytokine, pituitary hormone, and glucocorticoidinduced regulator S, NIKOLICPATERSON BUCALA R, - Bucala R. Lipid and lipoprotein oxidation: basic mechanisms and unresolved questions in 2: 291-307. [PMID: 27406410](https://pubmed.ncbi.nlm.nih.gov/27406410), characterization of structure, backbone and glutathione binding of the human macrophage migration inhibitory factor (MIF)](http://www.ncbi.nlm.nih.gov/pubmed/8897610)M\u00fchlhahn P, Czisch M, Georgescu J, Renner C, Ross A, Holak T, Bernhagen J, Bucala R. NMR characterization of structure, backbone dynamics, and glutathione binding of the human macrophage migration inhibitory factor Mattiace L, Bucala R, Vlassara H. Glycation and microglial reaction in lesions of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment](http://www.ncbi.nlm.nih.gov/pubmed/8840295)Soulis T, Cooper M, Vranes D, Bucala R, Jerums G. Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment Kidney International 1996, 50: 627-634. modifications of N-boc-arginine and N-CBZ-lysine by methylglyoxal Progress in Role of Advanced Glycation End Product Receptors](http://www.ncbi.nlm.nih.gov/pubmed/8674896)Vlassara H, Bucala R. Recent Progress in Advanced Glycation and Diabetic Vascular Disease: Role of Advanced Glycation s65-s66. [PMID: 8674896](https://pubmed.ncbi.nlm.nih.gov/8674896), 10.2337/diab.45.3.s65](https://doi.org/10.2337/diab.45.3.s65). A, Bernhagen J, Teichberg S, Basgen J, Wagle D, Shih D, Terlecky I, Bucala R, A, J, Ulrich P. An agent cleaving glucose-derived protein crosslinks regulator of W. Hydroxyalkenal Formation Induced by Advanced Glycosylation of Low Density Lipoprotein () Journal [DOI: 10.1074/jbc.271.6.2892](https://doi.org/10.1074/jbc.271.6.2892). - the effect of hyperglycemia on atherogenesis and can it be reversed by aminoguanidine? Diabetes Research And Clinical Practice 1996, 30: s157-s159. [DOI: 10.1016/s0168-8227(96)80061-1](https://doi.org/10.1016/s0168-8227(96)80061-1). - Sun H, Swope S, Bernhagen J, Bucala R, Lolis E. The subunit structure of human macrophage migration inhibitory factor: evidence for a trimer Protein Inhibitory Factor (MIF) [DOI: the effect of hyperglycemia on atherogenesis and can it be reversed by aminoguanidine? Diabetes Research And Clinical Practice 1996, implications for lipoprotein clearance and atherogenesis](http://www.ncbi.nlm.nih.gov/pubmed/9044301)Bucala R. Site-specific modification of apolipoprotein B by advanced glycosylation end-products: implications for lipoprotein H, Koike T. The role advanced glycosylation end-products in the E, Bucala R. Model studies of the maillard reaction of Arg-Lys with D-ribose Bioorganic & Medicinal Chemistry 1995, 5: [DOI: 10.1016/0960-894x(95)00513-s](https://doi.org/10.1016/0960-894x(95)00513-s). - Bucala R, Vlassara H. Advanced glycosylation end products in diabetic renal and vascular disease American Journal Of Kidney Diseases 1995, 7503061](https://pubmed.ncbi.nlm.nih.gov/7503061), [DOI: 10.1016/0272-6386(95)90051-9](https://doi.org/10.1016/0272-6386(95)90051-9). Tracey K, W, Manogue K, the and Cells the Gland](http://www.ncbi.nlm.nih.gov/pubmed/8612200)Nishino Shiiki Calandra of Macrophage Migration Inhibitory Factor (MIF) to Secretory Granules within the Corticotrophic and Thyrotrophic Cells of the during the Maillard reaction](https://doi.org/10.1016/0960-894x(95)00375-4)Al-Abed Y, Bucala R. N-carboxymethyllysine formation by direct addition of glyoxal to lysine during the Maillard reaction Bioorganic & Medicinal Chemistry Letters 1995, 5: 2161-2162. [DOI: 10.1016/0960-894x(95)00375-4](https://doi.org/10.1016/0960-894x(95)00375-4). - Calandra T, Bernhagen J, Metz Bacher M, Donnelly T, Cerami A, Bucala R. MIF as end products precedes and correlates with early manifestations of renal and retinal disease in diabetes](https://doi.org/10.2337/diabetes.44.7.824)Beisswenger P, Makita Z, Curphey T, Moore L, Jean S, Brinck-Johnsen T, Bucala R, Vlassara H. Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes Diabetes 1995, 44: 824-829. [DOI: 10.2337/diabetes.44.7.824](https://doi.org/10.2337/diabetes.44.7.824). [Formation of Immunochemical Advanced Glycosylation End Products Precedes and Correlates With Early Manifestations of Renal and Retinal Disease in Diabetes](http://www.ncbi.nlm.nih.gov/pubmed/7789650)Beisswenger P, Makita Z, Curphey T, Moore L, Jean S, Brinck-Johnsen T, Bucala R, Vlassara H. Formation of Immunochemical Advanced Glycosylation End Products Precedes and Correlates With Early Manifestations of Renal and Retinal Disease in Diabetes Diabetes 1995, 44: 824-829. [PMID: 7789650](https://pubmed.ncbi.nlm.nih.gov/7789650), [DOI: 10.2337/diab.44.7.824](https://doi.org/10.2337/diab.44.7.824). [Identification of of Apolipoprotein B Modification by Advanced Glycosylation End Products Blocking Uptake by the Low Density Lipoprotein Receptor *](http://www.ncbi.nlm.nih.gov/pubmed/7738020)Bucala R, Mitchell R, Arnold K, Innerarity T, Vlassara H, Cerami A. Identification of the Major Site of Apolipoprotein B Modification by Advanced Glycosylation End Products Blocking Uptake by the Low Density Lipoprotein Receptor * Journal Of Biological Chemistry 1995, 270: 7738020](https://pubmed.ncbi.nlm.nih.gov/7738020), [DOI: 10.1074/jbc.270.18.10828](https://doi.org/10.1074/jbc.270.18.10828). within the vascular lesions and glomeruli in diabetic nephropathy](http://www.ncbi.nlm.nih.gov/pubmed/7890283)Nishino T, Horii Y, Shiiki H, Yamamoto H, Makita Z, Bucala R, Dohi K. Immunohistochemical detection of advanced glycosylation end products within the vascular lesions and glomeruli in diabetic nephropathy Prevents Acute Inflammation and Endotoxin Lethality](http://www.ncbi.nlm.nih.gov/pubmed/8529104)Bianchi M, Ulrich P, Bloom O, Meistrell M, Zimmerman G, Schmidtmayerova H, Bukrinsky M, Donnelley T, Bucala R, Sherry B, K, A, K. An Macrophage Arginine Transport and Nitric Oxide Production (CNI-1493) Prevents Acute Inflammation and Endotoxin DeSimone C, Cerami A, Bucala R. A role for DNA mutations in diabetes-associated teratogenesis in transgenic embryos Diabetes 1995, [DOI: 10.1007/978-94-011-1468-4_260](https://doi.org/10.1007/978-94-011-1468-4_260). macrophage migration inhibitory factor](https://doi.org/10.1007/978-94-011-1468-4_393)Kaiser T, Bernhagen J, Bucala R, Paulus G, Voelter W. Different approaches for solid phase peptide synthesis of mouse macrophage migration inhibitory factor 1995, 853-854. [DOI: 10.1007/978-94-011-1468-4_393](https://doi.org/10.1007/978-94-011-1468-4_393). - Bucala R, Cerami A. Glucose Significance, and Prospects for Pharmacological Inhibition](http://www.ncbi.nlm.nih.gov/pubmed/7619388)Bucala R, Vlassara H. Advanced Glycosylation Endproducts in Diabetic Renal Disease: Clinical Measurement, Pathophysiological Significance, and Prospects for 160-170. DeSimone C, Cerami A, Bucala R. A Role for DNA Mutations in Diabetes-Associated Teratogenesis in Transgenic macrophage cytokine and its role in endotoxic shock](http://www.ncbi.nlm.nih.gov/pubmed/7737686)Bucala R. Identification of MIF as a new pituitary hormone and macrophage cytokine and its role J, Hogan M, Cerami A. Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue endproducts (AGE-LDL) lies within a 28-kDa region located N-terminal to the LDL-receptor binding domain](https://doi.org/10.1016/0021-9150(94)93201-8)Bucala R, Mitchell R, Vlassara H, Cerami A. The primary site of apolipoprotein-B modification by advanced glycosylation endproducts (AGE-LDL) lies within a 28-kDa region located N-terminal LDL-receptor binding domain Cerami A, Bucala R. MIF IS AN IMPORTANT MEDIATOR OF THE TOXIC SHOCK SYNDROME. Shock 1994, 2: 16. [DOI: 10.1097/00024382-199409001-00007](https://doi.org/10.1097/00024382-199409001-00007). - Al-Abed Y, Voelter W, Cerami A, Bucala R. Identification of 4-hydroxyhexenal as an oxidation product formed LDL endproducts: Role in diabetic and nondiabetic disease 1994, migration inhibitory factor is a neuroendocrine mediator of endotoxaemia In 1994, - Bernhagen R. The emerging role of MIF in septic shock infection Biotherapy 1994, Cerami A, Bucala R. Comparative analysis of DNA mutations in lacI transgenic mice with age The FASEB Journal 1994, 8: 545-550. and GRO by synovial fibroblasts in chronic arthritis: Possible role in growth regulation](http://www.ncbi.nlm.nih.gov/pubmed/8003635)Hogan M, Sherry B, Ritchlin C, Fabre M, Winchester R, Cerami A, Bucala R. Differential expression of the small inducible cytokines GRO and GRO by synovial fibroblasts in chronic arthritis: Possible role E, Rodby R, Cerami A, Bucala R. Hemoglobin-AGE: A Circulating Advanced Glycosylation: Chemistry, Biology, and Implications for Diabetes and Aging 1992, 1-34. Wang P, Rutherford J. Labile T-wave changes caused by respiratory variation in a patient with unstable angina International Journal Of of lysine adducts with 16-hydroxyestrone and cortisol The Journal Of Fishman J. Determination of 16 alphahydroxyestrone by radioimmunoassay in systemic and glucocorticoid toxicity](http://www.ncbi.nlm.nih.gov/pubmed/3842583)Bucala modification Pathological implications Cerami A. Glucocorticoid-lens protein adducts in experimentally induced steroid cataracts 1985, 40: 853-863. [PMID: 4018168](https://pubmed.ncbi.nlm.nih.gov/4018168), [DOI: 10.1016/0014-4835(85)90130-7](https://doi.org/10.1016/0014-4835(85)90130-7). [Increased levels pregnancy and in systemic lupus erythematosus.](http://www.ncbi.nlm.nih.gov/pubmed/3920233)BUCALA R, LAHITA R, FISHMAN J, CERAMI A. Increased levels of 16 alpha-hydroxyestrone-modified proteins in pregnancy and in systemic lupus erythematosus. The Journal Of Clinical BRADLOW H, FISHMAN J. Role of Sex Steroids in Systemic Lupus Erythematosus (SLE) 1985, 33: and aggregate formation: In vitro and in vivo studies](http://www.ncbi.nlm.nih.gov/pubmed/4065253)Bucala R, Manabe S, Urban R, Cerami A. of lens crystallins by prednisolone induces sulfhydryl oxidation and aggregate formation: In vitro and in vivo Eye 41: 353-363. 10.1016/s0014-4835(85)80026-9](https://doi.org/10.1016/s0014-4835(85)80026-9). - A. The reaction of 16hydroxyestrone with erythrocytes in vitro and in formed by the nonenzymatic reaction of 16-hydroxyestrone with albumin](http://www.ncbi.nlm.nih.gov/pubmed/6656775)Bucala R, Cerami A. Characterization of antisera to the addition product formed by the nonenzymatic reaction of 16-hydroxyestrone of a Perfluorocarbon Blood Substitute [PMID: 6844922](https://pubmed.ncbi.nlm.nih.gov/6844922), [DOI: 10.1126/science.6844922](https://doi.org/10.1126/science.6844922). Biography Richard Bucala, MD, PhD, is a Professor of Medicine, Pathology, and Epidemiology & Public Health. He studies the mechanisms by which protective immune responses lead to immunopathology, focusing on MIF-family cytokines and their genetics, which his group first cloned and characterized experimentally. Currently, his laboratory is leading multidisciplinary efforts to develop immunotherapies tailored to an individual's genetic makeup. An anti-MIF antibody developed by the group is undergoing clinical testing in oncology, and an anti-MIF receptor antibody, recently FDA approved, is under evaluation in SLE. Dr. Bucala also is credited with the discovery of the fibrocyte, which is being targeted therapeutically in different fibrosing disorders. He is a co-founder of Cytokine Networks and of MIFCOR, a biotechnology startup begun as a student-advised project. Dr. Bucala was elected to the American Society for Clinical Investigation and the Association of American Physicians. He is the Editor-in-Chief of Arthritis & Rheumatology and has served on numerous advisory boards for the NIH, the pharmaceutical industry, academia, and private foundations. Titles - Waldemar Von Zedtwitz Professor of Medicine (Rheumatology) and Professor of Pathology and of Epidemiology (Microbial Diseases) - Chief, Rheumatology, Allergy, & Immunology - Rheumatologist in Chief, Rheumatology - Affiliated Faculty, Yale Institute for Global Health Education & Training - FellowHospital for Special Surgery (1991) - ResidentBrigham & Women's Hospital/Harvard Medical School (1988) - MDCornell College (1986) - PhDRockefeller University (1985) - Visiting FellowInstitut Pasteur, Paris (1985) - BSYale University (1979) - MSYale University (1979) Additional Information - American Association of Physicians: (2009) - American Society for Clinical Investigation: (1996) - Arthritis & Rheumatology (2015 - Present): Editor-in-Chief - Journal of Immunology (2010 - 2015): Associate Editor - Alumni Schools Committee (2008 - 2012): Member - NIH (2006 - 2012): NIH Biodefense and Chemical Countermeasures - Shin JJ, Fan W, Par-Young J, Piecychna M, Leng L, Israni-Winger K, Qing H, Gu J, Zhao H, Schulz WL, Unlu S, Kuster J, Young G, Liu J, Ko AI, Garcia A, Sauler M, Wisnewski AV, Young L, Ordu\u00f1a A, Wang A, Klementina O, Garcia AB, Hegyi P, Armstrong ME, Mitchell P, Ordiz DB, Garami A, Kang I, Bucala R. MIF is a Common Genetic Determinant of COVID-19 Wang W, Zalavadia A, Makarav V, Troike K, McGraw M, Rabljenovic A, Lauko A, Neumann C, Roversi G, Waite N, Tran T, McCortney K, Steffens A, Diaz-Montero C, Brown J, Egan K, Horbinski C, Barnholtz-Sloan J, Rajappa P, Vogelbaum M, Bucala T, Ahluwalia M, Lathia J. The SNP rs755622 is associated with glioblastoma. JCI 2023 [PMID: 37252795](https://pubmed.ncbi.nlm.nih.gov/37252795), [DOI: 10.1172/jci.insight.160024](https://doi.org/10.1172/jci.insight.160024). - Ye Mahmood D, Leng L, Bucala R, Vera P. Urothelial Oxidative Stress and ERK Activation 2023, 12: 1440. [PMCID: PMC10217556](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217556), [DOI: 10.3390/cells12101440](https://doi.org/10.3390/cells12101440). - Huang Y, Cui D, Chen L, Tong H, Wu H, Muller G, Qi Y, Wang S, Xu J, Gao X, Fifield K, Wang L, Xia Z, Vanderluit J, Liu S, Leng L, Sun G, McGuire J, Young L, Bucala R, Qi D. A pref-1-controlled non-inflammatory mechanism PMC10239698](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239698), [DOI: 10.1016/j.isci.2023.106923](https://doi.org/10.1016/j.isci.2023.106923). - Huang Y, Cui D, Chen L, Tong H, Wu H, Muller G, Qi Y, Wang S, Xu J, Gao X, Fifield K, Wang L, Xia Z, Vanderluit J, Liu S, Leng L, Sun G, McGuire J, Young L, Bucala R, Qi D. A pref-1-controlled non-inflammatory mechanism Anniversary of The Journal of Rheumatology: The Past, Present, and Future of Rheumatology](http://www.ncbi.nlm.nih.gov/pubmed/36587952)Masi A, Bucala R. Reflections for the 50th Anniversary of The Journal of Rheumatology: The Past, Present, and Future of Rheumatology The malaria vaccine 2023 [DOI: 10.33424/futurum362](https://doi.org/10.33424/futurum362). [Correction to: Clinical features and high-risk indicators of central nervous system involvement in primary Sj\u00f6gren's syndrome](http://www.ncbi.nlm.nih.gov/pubmed/36565380)Fan W, Par-Young J, Li K, Zhang Y, Xiao P, Hua L, Leng L, Chen X, Bucala R. Correction to: Clinical features and high-risk indicators of central nervous system involvement in primary Sj\u00f6gren's of central nervous system involvement in primary Sj\u00f6gren's syndrome](http://www.ncbi.nlm.nih.gov/pubmed/36401063)Fan W, Par-Young J, Li K, Zhang Y, Xiao P, Hua L, Leng L, Chen X, Bucala R. Clinical features and high-risk indicators of central nervous system involvement in primary Sj\u00f6gren's Radomir L, Lewinsky H, Leng L, Bucala R, Becker-Herman S, Shachar I. CD74 as a regulator of transcription in normal B cells Reports Increased Proportions of the Highly Permissive Th17-like Cell Profile during HIV Infection](http://www.ncbi.nlm.nih.gov/pubmed/36298774)Trifone C, Baquero L, Czernikier A, Benencio P, Leng L, Laufer N, Quiroga MF, Bucala R, Ghiglione Y, Turk G. Macrophage Migration Inhibitory Factor (MIF) Promotes Increased Proportions of the Highly Permissive Th17-like Cell Profile during HIV Poor Immune Responses to COVID-19 mRNA Vaccines in Patients with Primary Antibody Deficiency](http://www.ncbi.nlm.nih.gov/pubmed/35713752)Shin JJ, Par-Young J, Unlu S, McNamara A, Park HJ, Shin MS, Gee RJ, Doyle H, Afinogenova Y, Zidan E, Kwah J, Russo A, Mamula M, Hsu FI, Catanzaro J, Racke M, Bucala R, Wilen C, Kang I. Defining Clinical and Immunological Predictors of Poor Immune Responses to COVID-19 mRNA Vaccines in Patients with Primary Antibody Deficiency Journal acute EAE in MIF-1-deficient female and male mice with a bifunctional MHCII-derived molecular construct](http://www.ncbi.nlm.nih.gov/pubmed/35738135)Vandenbark AA, Meza-Romero R, Wiedrick J, Gerstner Seifert H, Kent G, M, Benedek G, Bucala R, Offner H. \"Near Cure\" treatment of severe acute EAE in MIF-1-deficient female and male mice with a bifunctional Leng L, Bucala R, Vera Oxidative Stress and HMGB1 Release Contribute to PAR4-Mediated Bladder Pain in Mice Signaling Axis in Alveolar Type II Epithelial Cells](https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2323)Kim S, Yang T, Peng X, Leng L, Bucala R, Lee P, Herzog E, Sauler M. Profibrotic Role for a Dysregulated D-Dopachrome Tautomerase-Cullin 3 Signaling Axis Alveolar Type II Epithelial Cells 2022, a2323-a2323. [DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2323](https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2323). - Yang T, Kim S, Leng L, Nouws J, Bucala R, Sauler M. The OXIDATIVE STRESS AND ERK SIGNALING CONTRIBUTE TO BLADDER PAIN MEDIATED BY MACROPHAGE MIGRATION INHIBITORY FACTOR AND HIGH MOBILITY GROUP BOX 1](https://doi.org/10.1097/ju.0000000000002529.05)Ye S, Ma F, Mahmood D, Meyer-Siegler K, Leng L, Bucala R, Vera P. MP07-05 BLADDER OXIDATIVE STRESS AND ERK SIGNALING CONTRIBUTE TO BLADDER PAIN MEDIATED BY MACROPHAGE MIGRATION INHIBITORY FACTOR AND HIGH MOBILITY GROUP BOX RP, Mostafavi H, Tang PCH, Bucala R, Teixeira MM, Taylor A, Zaid A, innate immune sensor responses in gingival epithelial cells](http://www.ncbi.nlm.nih.gov/pubmed/35100435)Kantrong N, Chang AM, Bamashmous RJ, Darveau RP. Macrophage migration inhibitory factor regulates specific innate immune sensor responses in gingival epithelial cells decrease stress, disease activity, and inflammatory cytokine levels in patients with autoimmune hepatitis](http://www.ncbi.nlm.nih.gov/pubmed/35434588)Alrabadi LS, Dutton A, Rabiee A, Roberts SJ, Deng L, JL, Assis DN. Mindfulness-based stress reduction may decrease stress, disease activity, and inflammatory cytokine levels in patients with autoimmune hepatitis autoimmunity Proceedings Of The National Academy Of Sciences Of The United States Of remodeling and contractile dysfunction through pyroptosis-evoked regulation of ferroptosis](http://www.ncbi.nlm.nih.gov/pubmed/35033649)Chen L, Yin Z, Qin X, Zhu X, Chen X, Ding G, Sun D, Wu NN, Fei J, Bi Y, Zhang J, Bucala R, Ren J, Zheng Q. CD74 ablation rescues type 2 diabetes mellitus-induced cardiac remodeling and contractile dysfunction through Receptors Are Differentially Expressed in Rheumatoid Arthritis Patients Evaluated by DAS28-ESR](http://www.ncbi.nlm.nih.gov/pubmed/35011861)S\u00e1nchez-Zuno GA, Bucala R, Hern\u00e1ndez-Bello Rom\u00e1n-Fern\u00e1ndez Receptors Are Differentially Expressed in Rheumatoid Arthritis Patients Evaluated by DAS28-ESR Journal X, Bucala R, Lewandowski LB, Hsieh E. Global Rheumatology J, Sauler M, Piecychna M, Pantouris G, Lolis L, J, Fingerle-Rowson G, Bucala R. MIF but not MIF-2 recruits inflammatory macrophages in an experimental polymicrobial sepsis model Brandt E, Koenen M, Djudjaj S, Schneider at the MIF Immune Susceptibility Locus](http://www.ncbi.nlm.nih.gov/pubmed/33844457)Yao J, Leng L, Fu W, Li J, Bronner C, Bucala R. ICBP90 Regulates MIF Expression, Glucocorticoid Sensitivity, and Apoptosis Mahmood D, Meyer-Siegler K, Menard R, Hunt D, Leng L, Bucala R, Vera P. MP08-05 BLADDER MACROPHAGE MIGRATION INHIBITORY F, Mahmood DFD, Meyer-Siegler KL, Menard CD74 and CXCR4, Inhibitory Factor (MIF) Contributes to Adipocyte Hypertrophy and Development of Obesity](https://doi.org/10.2337/db21-197-lb)CHEN L, HUANG Y, LI L, ZABIHI H, QI Y, LENG L, SUN G, BUCALA R, QI D. 197-LB: The Regulation of HSL by Macrophage Migration Inhibitory Factor (MIF) Contributes to Adipocyte Hypertrophy and Development of Price CC, V, Kaman K, Davis M, Chupp G, Bucala R, Kaminski N, Topal JE, Dela Cruz patients with alcohol-associated hepatitis](http://www.ncbi.nlm.nih.gov/pubmed/33945507)Poulsen KL, Fan X, Kibler CD, Huang E, Wu X, McMullen MR, Leng L, Bucala R, Ventura-Cots M, Argemi J, Bataller R, Nagy LE. Role of MIF in coordinated expression of hepatic chemokines in aging UMHET3 male mice; nicotinamide riboside and three other drugs do not affect lifespan in either sex](http://www.ncbi.nlm.nih.gov/pubmed/33788371)Harrison DE, Strong R, Reifsnyder P, Kumar N, Fernandez E, Flurkey K, Javors A, Bitto A, Sindler AL, Cortopassi G, Kavanagh K, Leng L, Bucala R, Rosenthal N, Salmon A, Stearns TM, Bogue M, Miller RA. 17aestradiol late in life extends lifespan in aging UMHET3 male mice; nicotinamide riboside and three other drugs do not affect lifespan in either sex Aging C, Gil-Yarom N, Kramer M, Barak A, Sever L, David K, Radomir L, Lewinsky H, Levi M, Friedlander G, Bucala R, Peled A, Shachar I. CD74 is a regulator colorectal cancer](http://www.ncbi.nlm.nih.gov/pubmed/33542244)Klemke L, via macrophage recruitment and angiogenesis in colorectal cancer Cell Is Linked to a Shift in NKT Cell Populations](http://www.ncbi.nlm.nih.gov/pubmed/33525493)Heinrichs D, Brandt EF, Fischer J, ML. Unexpected Pro-Fibrotic Effect of MIF in Non-Alcoholic Steatohepatitis Is Linked to a Shift in NKT Cell inhibitory predicts outcome in patients with acute decompensation of cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/33659891)Wirtz TH, Reuken PA, Jansen C, Fischer P, C, Emontzpohl C, Rei\u00dfing T, ML. Balance between macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cell abnormalities in mice\" [Leuk. Res. 96C (2020) 106428]](http://www.ncbi.nlm.nih.gov/pubmed/33288274)Liu T, Ahmed Shirai CL, Shao J, Nunley R, Bucala A, M, Walter MJ. Corrigendum to \"Haploinsufficiency of multiple del(5q) genes induce B cell abnormalities in mice\" [Leuk. Res. receptor that blocks atherogenic inflammation by agonist-specific targeting](http://www.ncbi.nlm.nih.gov/pubmed/33239628)Kontos C, El Bounkari O, Krammer C, Sinitski D, Hille K, Zan C, Yan G, Wang S, Gao Y, Brandhofer M, Megens RTA, Hoffmann A, Pauli J, Asare M, Weber C, Kapurniotu A, Bernhagen J. Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific [DOI: 10.1038/s41467-020-19764-z](https://doi.org/10.1038/s41467-020-19764-z). Pfau D, Wu X, Rao V, Testani J, Margulies K, Bucala R, Young L. 14834: Protective Role of Cardiomyocyte-derived Ddt in Ischemic Cardiomyopathy Circulation 2020, 142 [DOI: 10.1161/circ.142.suppl_3.14834](https://doi.org/10.1161/circ.142.suppl_3.14834). - Kim S, Wan F, Zhang X, Zhang Y, Ifedigbo E, Leng L, Bucala R, Lee P, Sauler M. MIF-CD74 Signaling Protects Against Endothelial Senescence in Chronic Obstructive Pulmonary Disease 2020, a4374-a4374. [DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4374](https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4374). - Kim S, Wan F, Zhang X, Zhang Y, Ifedigbo E, Leng L, Bucala R, Sauler M, Lee P. MIFCD74 Signaling Protects against Endothelial Senescence in Chronic Obstructive Pulmonary The FASEB MEDIATES BLADDER PAIN](https://doi.org/10.1097/ju.0000000000000867.013)Ye Ma F, Meyer-Siegler K, Leng L, Bucala R, Vera* P. MP28-13 INTRAVESICAL MACROPHAGE FACTOR Urology 2020, 203 [DOI: 10.1097/ju.0000000000000867.013](https://doi.org/10.1097/ju.0000000000000867.013). [GENE-26. HOST GENETIC VARIATIONS IN MACROPHAGE MIGRATION INHIBITOR FACTOR CONFER WORSE PROGNOSIS IN GLIOBLASTOMA](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6847914)Otvos B, Grabowski M, Alban T, Golubovsky R, M, J. GENE-26. HOST GENETIC VARIATIONS IN MACROPHAGE MIGRATION INHIBITOR FACTOR CONFER GROWTH](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6847354)Alban TARGETING IMMUNOSUPPRESSIVE MYELOID SUPPRESSOR VIA May Contribute Disseminated Coccidioidomycosis Susceptibility](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810323)Odio C, Leng L, Siu E, Piecychna M, Galgiani J, Holland S, Bucala R. 2598. Macrophage Migration Inhibitory Factor May Contribute to Disseminated Coccidioidomycosis Susceptibility Open Forum Infectious Diseases 2019, 6: s903-s903. [DOI: 10.1093/ofid/ofz360.2276](https://doi.org/10.1093/ofid/ofz360.2276). S. 830 Can CD74 Predict Treatment Response to Anti-TNF Agents in Inflammatory Bowel Disease? The American Induced Heart Failure](https://doi.org/10.1161/res.125.suppl_1.875)Ma Y, Hu X, Wu X, Pfau D, Leng L, Bedi K, Margulies K, Bucala R, Young L. Abstract 875: Cardiomyocyte Derived DDT Protects Against Myocardial Infarction Induced Heart Failure Circulation Research 2019, 125 [DOI: 10.1161/res.125.suppl_1.875](https://doi.org/10.1161/res.125.suppl_1.875). - Ardito T, Nouws J, Kim S, Zhang Y, Bucala R, Lee P, Sauler M. Protective Role of D-Dopachrome Tautomerase (MIF2) in Chronic Obstructive Pulmonary Disease 2019, a5374-a5374. [DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5374](https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5374). - Tilstam P, Schulte W, Holowka T, Kim B, Piecychna M, Pantouris G, Lolis E, Leng L, Bernhagen J, Bucala R. Selective Recruitment of Lethal Pro-inflammatory Macrophages in Sepsis by MIF but not Of MIF and MIF2 have distinct but synergistic roles in CIA The Journal Of Immunology 2019, 180.13-180.13. Schulte W, Maerz L, Moeckel G, Bucala R. Chapter 83 Adaptive Immunity and Critical Illness 2019, 483-487. [DOI: 10.1016/b978-0-323-44942-7.00083-2](https://doi.org/10.1016/b978-0-323-44942-7.00083-2). - Hannan MT, Bucala R. A Fresh New Look, and a Fresh New Journal Arthritis Care & Research 2018, 71: associated with reduced diffusing capacity](http://www.ncbi.nlm.nih.gov/pubmed/30520689)Zhang C, Ramsey C, Berical A, Yu L, Leng L, McGinnis K, Song Y, Michael H, McCormack M, Allore H, Morris A, Crothers K, Bucala R, Lee P, Sauler M. A functional macrophage migration inhibitory factor promoter polymorphism is associated with reduced diffusing capacity American Journal Of Physiology - Lung Cellular And Molecular Physiology in Sepsis by Macrophage Migration Inhibitory Factor But Its Homologue MIF2](https://doi.org/10.1016/j.jamcollsurg.2018.07.118)Schulte W, Tilstam P, Holowka T, Piecychna M, Leng L, Bernhagen J, Bucala R. Selective Recruitment of a Lethal Macrophage Subset in Sepsis by Macrophage Migration Inhibitory Factor But Not Its Homologue MIF2 Journal Of The American College Of [DOI: 10.1016/j.jamcollsurg.2018.07.118](https://doi.org/10.1016/j.jamcollsurg.2018.07.118). muscle cells exerts atheroprotective European Heart Journal 2018, 39 [DOI: 10.1093/eurheartj/ehy563.4148](https://doi.org/10.1093/eurheartj/ehy563.4148). - Pantouris G, Ho J, Shah D, Syed M, Leng L, Bhandari V, Bucala R, Batista V, Loria J, Lolis E. Dynamics Chemie 2018, 130: 7234-7237. Bucala R, Meyer-Siegler K, Vera P. PD55-03 PAR4 ACTIVATION AS A PERSISTENT MODEL OF BLADDER PAIN: ROLE OF MIF inhibitory factor in non-alcoholic steatohepatitis is associated with a shift in natural killer T cell populations](https://doi.org/10.1016/s0168-8278(18)31017-1)Heinrichs D, Brandt E, Fischer P, Koehncke J, Wirtz T, Djudjaj S, Boor P, Bucala C, J, M. FRI-068 Novel properties of macrophage migration inhibitory factor in non-alcoholic steatohepatitis is associated with a shift in natural killer T cell populations Journal Of Hepatology 2018, 68: s392. [DOI: 10.1016/s0168-8278(18)31017-1](https://doi.org/10.1016/s0168-8278(18)31017-1). [PS-083 Protection from Gao-Binge induced liver injury in Mif-/- Mice is associated with decreased ER stress](https://doi.org/10.1016/s0168-8278(18)30313-1)Poulsen K, Mcmullen M, Sheehan M, Leng L, Bucala R, Nagy L. PS-083 Protection from Gao-Binge induced liver injury in Mif-/- Mice is associated with decreased ER stress Journal Of Hepatology 2018, 68: s47-s48. receptor (CD74+) expressing memory T cell subpopulation is sufficient to transfer inflammatory arthritis](https://doi.org/10.4049/jimmunol.198.supp.156.3)Doherty E, Piecychna M, Leng L, Bucala R. Adoptive transfer of a novel MIF receptor (CD74+) expressing memory T cell subpopulation is sufficient to transfer inflammatory arthritis The Journal 2017, 198: 156.3-156.3. [DOI: 10.4049/jimmunol.198.supp.156.3](https://doi.org/10.4049/jimmunol.198.supp.156.3). [Macrophage an Upstream Regulator of NLRP3 Expression and Subsequent IL-1beta Production in Human Monocytes in Response to Lupus U1-snRNP Immune Complex](https://doi.org/10.4049/jimmunol.198.supp.210.3)Shin M, Kang Y, Leng L, Bucala R, Kang I. Macrophage Migration Inhibitory Factor Serves As an Upstream Regulator of NLRP3 Expression and Subsequent IL-1beta Production in Human Monocytes in Response to Lupus U1-snRNP hepatic inflammation in a model of autoimmune liver disease](https://doi.org/10.1016/s0168-8278(17)31067-x)Roberts S, Leng L, Soroka C, Boyer J, Bucala T-cell proliferation and hepatic inflammation in a model of autoimmune liver disease Journal Of Hepatology 2017, F. CD74-dysregulation of placental Patients Exhibited A, Kraemer S, Emontzpohl C, J, Bucala R, Weber C, Bernhagen J. Abstract 16602: The Clinical Significance of Mif, Mif-2 and Mif Genotype in Patients Exhibited [DOI: F, R, Herse F. 042: Cd74-dysregulation of 66 [DOI: 10.1161/hyp.66.suppl_1.042](https://doi.org/10.1161/hyp.66.suppl_1.042). - Bucala R. SP0184 Selecting the Best Journal for Communicating Research Findings Annals Of The Rheumatic Diseases 2015, 74: 45. [DOI: 10.1136/annrheumdis-2015-eular.6820](https://doi.org/10.1136/annrheumdis-2015-eular.6820). - Das R, Larose M, Hergott Leng Bucala R, Weiser J. 1677Macrophage migration inhibitory factor (MIF) promotes clearance of pneumococcal colonization Open Forum Diseases 1: s448-s448. [PMCID: PMC5782292](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782292), [DOI: 10.1093/ofid/ofu052.1223](https://doi.org/10.1093/ofid/ofu052.1223). leukocyte derived macrophage migration inhibitory factor in inflammatory responses remodelling myocardial infarction' [J Mol Cell Kanellakis P, Kiriazis H, Morand E, Bucala R, Dart A, Du X, Gao X. Erratum to 'Differential roles of cardiac and leukocyte derived macrophage migration inhibitory factor in inflammatory responses remodelling myocardial infarction' [J Mol Cell Cardiol 69 Cellular Cardiology 2014, 75: 198. [DOI: 10.1016/j.yjmcc.2014.08.005](https://doi.org/10.1016/j.yjmcc.2014.08.005). - Blakaj A, Chi X, Mourad W, Herzog E, Leng L, Bucala R. Metallothioneins in Fibrosis: Implications for Radiation-Induced Fibrosis International Oncology Biology Physics 2014, 90: s684-s685. [DOI: 10.1016/j.ijrobp.2014.05.2011](https://doi.org/10.1016/j.ijrobp.2014.05.2011). - Greene M, Roland A, Pritzker L, Carlson C, Bucala R, Miller R, Loeser R. Deletion of macrophage migration inhibitory factor reduces severity of osteoarthritis in mice Osteoarthritis And Cartilage 2014, 22: s58-s59. [DOI: 10.1016/j.joca.2014.02.122](https://doi.org/10.1016/j.joca.2014.02.122). - Sun T, Bucala R. The Scientific and Medical Challenge of Malaria 2014, 189-215. [DOI: 10.1142/9789814405584_0008](https://doi.org/10.1142/9789814405584_0008). - Montgomery R, Bucala R, Bockenstedt L. Memoriam: Stephen E. I, Kay S, Aloshin A, Sagi I, Goldenberg D, Leng L, Bucala R, Herishanu Y, Haran M, Shachar I. CD84 is a survival receptor for chronic lymphocytic leukemia cells (P2044) The Journal Of Immunology 2013, 190: 132.12-132.12. [DOI: 10.4049/jimmunol.190.supp.132.12](https://doi.org/10.4049/jimmunol.190.supp.132.12). - Benedek G, Meza-Romero Andrew Leng L, Burrows G, Bourdette D, Offner H, Bucala R, Vandenbark A. Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effects (P5221) The Journal 190: 67.4-67.4. lupus erythematosus and prospects for therapeutic intervention](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467510)Bucala R. Role of MIF gene polymorphisms in systemic lupus erythematosus and prospects for therapeutic intervention Arthritis Research 2012, 14: a33. [PMCID: using a knockout mouse approach](https://doi.org/10.1016/j.bbi.2012.07.064)Bay-Richter C, Janelidze S, Bucala R, Deierborg T, Brundin L. 40. Antidepressant effects of macrophage migration inhibitory factor using a knockout mouse approach Brain Behavior And Immunity 2012, 26: s11-s12. [DOI: 10.1016/j.bbi.2012.07.064](https://doi.org/10.1016/j.bbi.2012.07.064). - Bucala R. MIF, MIF the Host Response 2012, 3-22. [DOI: 10.1142/9789814335362_0001](https://doi.org/10.1142/9789814335362_0001). [1240 A FUNCTIONAL ROLE OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) FOR FATTY LIVER DISEASE AND OBESITY IN MICE](https://doi.org/10.1016/s0168-8278(12)61252-5)Heinrichs D, Knauel M, Nellen A, Trautwein C, Bucala R, J, H. A ROLE OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) FOR FATTY LIVER DISEASE AND OBESITY IN Journal Of Hepatology 2012, 56: s491. [DOI: Factor (MIF) for liver steatosis in mice by activation of AMP kinase](https://doi.org/10.1055/s-0031-1295805)Heinrichs D, Knauel M, Nellen A, Schmitz P, Trautwein C, Bucala R, Bernhagen J, Wasmuth H. A functional role of Macrophage Migration Inhibitory Factor (MIF) for liver steatosis in mice by activation AMP Zeitschrift 2012, Receptor Tyrosine Phosphatase Zeta Regulate B Cell Survival in Health and Disease in a Pathway Induced by CD74](https://doi.org/10.1016/j.clml.2011.09.024)Cohen S, Shoshana O, Zelman-Toister E, Maharshak N, Ehrenreich I, Gordin M, Shvidel L, Haran M, Leng L, Bucala R, Harroch S, Shachar I. 1.23 The Cytokine Midkine and its Receptor Tyrosine Phosphatase Zeta Regulate B Cell Survival in Health and Disease in a Pathway Induced by CD74 Clinical Lymphoma IN EXPERIMENTAL LIVER FIBROSIS VIA CD74 AND AMPK](https://doi.org/10.1016/s0168-8278(11)61040-4)Heinrichs Jung M, Offermanns C, Berres M, Nellen A, Schmitz P, Leng L, Bucala R, C, C, J, Wasmuth H. INHIBITORY FACTOR IN EXPERIMENTAL LIVER FIBROSIS Schmitz P, Bucala R, J, H. Systemic Fibrosis R. Abstract: TISSUE AND IMPAIRS INSULIN RESISTANCE AND ASSOCIATED ATHEROSCLEROSIS IN A MODEL OF COMBINED DISEASE](https://doi.org/10.1016/s1567-5688(10)70148-3)Kleemann R, Verschuren L, Wielinga P, Voshol P, van Erk M, Fingerle-Rowson G, van Dijk K, M, Bernhagen J, Bucala Kooistra T. MIF-DEFICIENCY REDUCES CHRONIC INFLAMMATION IN ADIPOSE TISSUE AND IMPAIRS INSULIN RESISTANCE AND ASSOCIATED ATHEROSCLEROSIS IN A MODEL OF COMBINED DISEASE Atherosclerosis Plus 2010, 11: 33. [DOI: 10.1016/s1567-5688(10)70148-3](https://doi.org/10.1016/s1567-5688(10)70148-3). [AV411 Vermeire L, Du X, Hodsdon M, Bucala R, Cappello M, Gross M, Gaeta F, Johnson K, Lolis E. AV411 (Ibudilast) and AV1013 are non-competitive a induced-fit infection](https://doi.org/10.1016/j.cyto.2009.07.571)Bosschaerts Morias Y, Engel D, Tacke F, Richard B, VandenDriessche T, Chuah M, De Baetselier P, Beschin A. Differentiation, activation and function of CD11b+Ly6C+ TNF/iNOS-producing dendritic [MRI in the era of nephrogenic systemic fibrosis: Review, controversies and suggestions for risk reduction](https://doi.org/10.37549/ar1683)Kuo P, Abu-Alfa A, Bucala R, Griffith J, Carlson K, Girardi M, Weinreb J, Cowper S. MRI in the era of nephrogenic systemic fibrosis: Review, controversies and suggestions for risk reduction Applied Radiology 2009, 22-33. [DOI: 10.37549/ar1683](https://doi.org/10.37549/ar1683). [MACROPHAGE MIGRATION INHIBITORY FACTOR ANTI-THROMBIN III COMPLEXES ARE DECREASED IN BLADDER CANCER PATIENT SERUM: COMPLEX FORMATION AS A POSSIBLE MECHANISM OF MIF INACTIVATION](https://doi.org/10.1016/s0022-5347(09)60867-3)Meyer-Siegler K, Cox J, Leng L, Bucala R, Vera P. MACROPHAGE MIGRATION INHIBITORY FACTOR ANTI-THROMBIN III COMPLEXES ARE DECREASED IN BLADDER CANCER PATIENT SERUM: COMPLEX FORMATION AS A POSSIBLE MECHANISM OF MIF INACTIVATION Investigative Urology 2009, 181: 304. Bucala R. Macrophage migration inhibitory factor and multiple organ dysfunction syndrome Journal Of Organ Dysfunction 2009, 5: 10-16. [DOI: 10.1080/17471060802443653](https://doi.org/10.1080/17471060802443653). - Doernberg S, Bucala R. CHAPTER 151 The Macrophage in Innate and Adaptive Immunity 2009, 784-788. [DOI: 10.1016/b978-1-4160-4252-5.50158-1](https://doi.org/10.1016/b978-1-4160-4252-5.50158-1). - Fg B, Dj N, Nm I, R, Metz C, Jp D, Atkins R. URINARY macrophage migration inhibitory factor (MIF) LEVELS REFLECT RENAL 2008, 5: a95-a95. [DOI: 10.1046/j.1440-1797.2000.abs26.x](https://doi.org/10.1046/j.1440-1797.2000.abs26.x). [URINE MIF BETWEEN HUMAN RENAL ALLOGRAFT REJECTION AND CYCLOSPORINE NEPHROTOXICITY](https://doi.org/10.1046/j.1440-1797.2000.abs41.x)Fg B, Dj N, Sj C, Cn M, Bucala R, Jp D, Atkins R. URINE MIF LEVELS DISCRIMINATE BETWEEN HUMAN RENAL ALLOGRAFT REJECTION AND [350: as a Target in Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation](https://doi.org/10.1016/j.bbmt.2007.12.360)Chang Y, Miklos S, Mueller G, Holler E, Lindner P, Leng L, Schubert T, Bucala R, Hildebrandt G. 350: Macrophage Migration Inhibitory Factor as a New Target in Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation Transplantation And Cellular Therapy 2008, 14: 128. [DOI: 10.1016/j.bbmt.2007.12.360](https://doi.org/10.1016/j.bbmt.2007.12.360). - Miklos S, Mueller G, Lindner P, Chang Y, Holler E, Bucala R, Hildebrandt G. Neutralization of Macrophage Migration Inhibitory Factor (MIF) Reduces 3234-3234. [DOI: 10.1182/blood.v110.11.3234.3234](https://doi.org/10.1182/blood.v110.11.3234.3234). - Quan T, Bucala R. Circulating Fibrocytes (MIF) Gene Polymorphisms are Associated with Susceptibility and Severity of Prostate Cancer](https://doi.org/10.1016/s0022-5347(18)31810-x)Meyer-Siegler K, Vera P, Iczkowski K, Bifulco C, Lee A, P, L, Bucala R. 1622: Macrophage Migration Inhibitory Factor (MIF) Gene Polymorphisms are Associated with Susceptibility and Severity of Prostate Cancer Investigative Urology 2007, 177: 537-538. [DOI: 10.1016/s0022-5347(18)31810-x](https://doi.org/10.1016/s0022-5347(18)31810-x). - Bucala Macrophage Migration Inhibitory Factor (MIF) Genetic Polymorphisms in Predicting the Development of Macrocytic Anemia in HIV+ Patients.](https://doi.org/10.1182/blood.v108.11.1254.1254)Lin S, Fultz S, Justice A, Bucala R, Vanasse K, Berliner N. The Role of Macrophage Migration Inhibitory Factor (MIF) Genetic Polymorphisms in Predicting the Development of Macrocytic Anemia in HIV+ Patients. Blood 2006, 108: 1254-1254. - Moss J, Metz in Cancer 2006 [DOI: 10.1002/3527600906.mcb.200400129](https://doi.org/10.1002/3527600906.mcb.200400129). - Bucala R. MIF and the Genetic Basis of Macrophage Responsiveness Current Immunology Reviews 2006, 2: 217-223. [DOI: 10.2174/157339506778018569](https://doi.org/10.2174/157339506778018569). [634: Mice with a Null Mutation For Macrophage Migration Inhibitory Factor Have Lower Stage Tumors in a Mouse Model of Bladder Cancer](https://doi.org/10.1016/s0022-5347(18)32880-5)Taylor J, Kuchel G, Hegde P, Voznesensky K, Bucala R, Pilbeam C. 634: Mice with a Null Mutation For Macrophage Migration Inhibitory Factor Have Lower Stage Tumors in a Mouse Model of Bladder Cancer Investigative Urology 2006, 175: 204. [DOI: 10.1016/s0022-5347(18)32880-5](https://doi.org/10.1016/s0022-5347(18)32880-5). [Tu-P10:495 Serum level of soluble receptor for advanced glycation end products is associated with circulating advanced glycation end products in type 2 diabetes](https://doi.org/10.1016/s1567-5688(06)81196-7)Tan K, Chow W, Shiu S, Bucala R, Betteridge D. Tu-P10:495 Serum level of soluble receptor for advanced glycation end products is associated with circulating advanced glycation end products in type 2 diabetes Atherosclerosis Plus 2006, 294. [DOI: 10.1016/s1567-5688(06)81196-7](https://doi.org/10.1016/s1567-5688(06)81196-7). [141: Macrophage Migration Factor Mediates Smooth Muscle Death in Bladder Outlet Obstruction](https://doi.org/10.1016/s0022-5347(18)34406-9)Taylor J, Zhu Q, Sasso D, Pilbeam C, Leng L, R, Kuchel G. 141: Macrophage Migration Inhibitory Factor Mediates Smooth Muscle Death in Bladder Outlet Obstruction Investigative Urology 2005, 173: 38. [DOI: 10.1016/s0022-5347(18)34406-9](https://doi.org/10.1016/s0022-5347(18)34406-9). [1409: Further Evidence for an Association between Macrophage Migration Inhibitory Factor and Prostate Cancer](https://doi.org/10.1016/s0022-5347(18)35543-5)Meyer-Siegler K, Iczkowski K, Leng L, Bucala R, Vera P. 1409: Further Evidence for an Association between Macrophage Migration Inhibitory Factor and Prostate Cancer Investigative Urology 2005, 382. [DOI: 10.1016/s0022-5347(18)35543-5](https://doi.org/10.1016/s0022-5347(18)35543-5). - Papoulis A, Cerami Bucala R. Glucose-mediated DNA Damage and Mutations: In and Vivo 2005, 249-253. [DOI: 10.1533/9781845698393.4.249](https://doi.org/10.1533/9781845698393.4.249). - Al-Abed NOVEL CROSSLINK EXHIBITING IMMUNOLOGICAL WITH FORMED T. Advanced Glycosylation of LDL: Role in Oxidative Modification and Diabetic Complications 2005, 286-291. [DOI: 10.1533/9781845698393.4.286](https://doi.org/10.1533/9781845698393.4.286). - Panagiotopoulos S, O'Brien R, Cooper M, Jerums G, Bucala R. Aminoguanidine Decreases Atherosclerotic Plaque Formation in the Cholesterol-Fed Rabbit 2005, 426. [DOI: 10.1533/9781845698393.7.426a](https://doi.org/10.1533/9781845698393.7.426a). - Fingerle-Rowson inhibitory factor are elevated in Pima Indians compared to Caucasians and are associated with insulin resistance](http://www.ncbi.nlm.nih.gov/pubmed/12552367)Vozarova B, Metz C, Stefan N, Hanson R, Lindsay R, Bucala R, Bogardus C, Tataranni P. Plasma concentrations of macrophage migration inhibitory factor are elevated in Pima Indians compared to Caucasians and are associated with insulin resistance Diabetologia 2002, 45: 1739-1741. [PMID: 12552367](https://pubmed.ncbi.nlm.nih.gov/12552367), [DOI: 10.1007/s00125-002-0896-4](https://doi.org/10.1007/s00125-002-0896-4). - Bucala R. New research International Congress Series 2002, 1245: 113-117. [DOI: 10.1016/s0531-5131(02)00886-5](https://doi.org/10.1016/s0531-5131(02)00886-5). - Bucala 10.1007/0-306-46870-0_10](https://doi.org/10.1007/0-306-46870-0_10). [Structure activity studies of macrophage migration inhibitory show a functional role for cysteine residues](https://doi.org/10.1007/0-306-46862-x_170)Bernhagen J, Kleemann R, Kapurniotu A, Bucala R, Brunner H. Structure activity studies of macrophage migration inhibitory factor show a functional role for cysteine residues 2002, 5: 400-401. [DOI: 10.1007/0-306-46862-x_170](https://doi.org/10.1007/0-306-46862-x_170). [Identification Teichberg Voelter W, Bucala R. Identification of a minimal peptide sequence of islet amyloid polypeptide (IAPP) in rat](http://www.ncbi.nlm.nih.gov/pubmed/10540199)Brown, Metz, Bucala, Atkins, Lan. of macrophage migration inhibitory factor in acute renal allograft rejection in the rat Clinical & and Suppresses Adverse AGE-mediated Cellular Effects In Vitro: A Potential AGE Sequestration Therapy for Diabetic Nephropathy?](http://www.ncbi.nlm.nih.gov/pubmed/11788787)Zheng F, Cai W, Mitsuhashi T, Vlassara H, Bucala R. Enhances Endproducts Vivo and Suppresses Adverse AGE-mediated Cellular Effects In Vitro: A Potential AGE Sequestration Therapy for Diabetic Nephropathy? Y, Bucala R, Z. Immunological Detection of a cells and promote angiogenesis in vivo](http://www.ncbi.nlm.nih.gov/pubmed/11641248)Hartlapp I, Abe R, Saeed R, Peng T, Voelter W, Bucala R, Metz C. Fibrocytes induce an angiogenic in endothelial cells and an important mediator in the pathogenesis of gastric inflammation in rats](http://www.ncbi.nlm.nih.gov/pubmed/11522746)Huang X, Hui C, Chen Y, Chun B, Wong Y, Fung P, Metz C, Cho C, Hui W, Bucala R, Lam S, Lan H. Macrophage migration inhibitory factor is an important mediator in the pathogenesis of gastric inflammation in rats H, Lawson J, FitzGerald G, Manogue K, Bucala R. Characterization of a Novel Hemoglobin-Glutathione Adduct That Is Elevated in Diabetic Patients 11488984](https://pubmed.ncbi.nlm.nih.gov/11488984), 10.1046/j.1440-1711.2001.01024.x](https://doi.org/10.1046/j.1440-1711.2001.01024.x). - Abe R, Donnelly Peng T, Bucala R, Metz C. Peripheral Blood Fibrocytes: Differentiation Pathway and Migration to Wound Sites The Journal DIAGNOSTIC TOOL IN HUMAN RENAL ALLOGRAFT REJECTION1](http://www.ncbi.nlm.nih.gov/pubmed/11455258)Brown F, Nikolic-Paterson D, Chadban S, Dowling J, Jose M, Metz C, Bucala R, Atkins R. URINE MACROPHAGE MIGRATION INHIBITORY FACTOR CONCENTRATIONS AS A DIAGNOSTIC TOOL IN HUMAN RENAL REJECTION1 Transplantation 2001, 71: 1777-1783. [PMID: 11455258](https://pubmed.ncbi.nlm.nih.gov/11455258), R, Peng T, Sailors J, Bucala R, Metz C. Regulation of the CTL Response by Macrophage Migration Inhibitory Factor Factor as a Secretory Protein from Rat Epididymis: Evidences for Alternative Release and Transfer to Spermatozoa](http://www.ncbi.nlm.nih.gov/pubmed/11474125)Eickhoff R, Wilhelm B, Renneberg H, Wennemuth G, Bacher M, Linder D, Bucala R, Seitz J, Meinhardt A. Purification and Characterization of Macrophage Migration Inhibitory Factor as a Secretory Protein from Rat Epididymis: Evidences for Alternative Release and Transfer to Spermatozoa 10.1007/bf03401836](https://doi.org/10.1007/bf03401836). X, Chen Y, Huang X, Metz C, Bucala R, Lau C, Lan H. De Novo Expression of Macrophage Migration Inhibitory Factor in Atherogenesis in precursor cells and the pathogenesis of M, Y, of Glycation End-Products for Cultured Cortical F, Atsumi T, Calandra T, Metz C, B, T, Bucala R. The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle Journal 408: 146-147. [PMID: 11089953](https://pubmed.ncbi.nlm.nih.gov/11089953), [DOI: 10.1038/35041654](https://doi.org/10.1038/35041654). - Lan H, Yang Nikolic-Paterson D, Yu X, Mu W, Isbel N, Metz C, Bucala R, Atkins R. Expression of macrophage migration inhibitory factor in human properties of macrophage migration inhibitory factor 359-366. 11100884](https://pubmed.ncbi.nlm.nih.gov/11100884), 10.1006/scbi.2000.0328](https://doi.org/10.1006/scbi.2000.0328). - Kim Mazzali M, Tang D, Metz C, Bucala R, Kivlighn S, Johnson R, Lan H. Involvement of Macrophage Migration Inhibitory Factor (MIF) in Experimental Uric Bradshaw J, Sutton W, Kuller L, Bucala R, Anderson D, Mossman S, Villinger F, Haigwood N. Macaque bloodderived antigenpresenting cells elicit after Ingestion of Plasmodium chabaudi-Infected Erythrocytes: Possible Role in the Pathogenesis of Malarial Anemia](http://www.ncbi.nlm.nih.gov/pubmed/10722628)Martiney J, Sherry B, Metz C, Espinoza Ferrer Calandra T, Broxmeyer H, Bucala R. Macrophage Migration Inhibitory Factor Release by Macrophages after Ingestion of Plasmodium chabaudi-Infected Erythrocytes: Possible Role in the Pathogenesis of Malarial migration inhibitory factor by endogenous glucocorticoids in L, Heumann D, M\u00e4nnel D, Bucala R, Glauser M. Protection from septic shock by neutralization of macrophage migration inhibitory factor Are Produced from Short Chain Sugars and Dicarbonyl Compounds in vivo](http://www.ncbi.nlm.nih.gov/pubmed/10859028)Takeuchi M, Makita Z, Bucala R, Suzuki T, Koike Y. Immunological Evidence that Non-carboxymethyllysine Advanced Glycation End-products Are Produced from Short Chain Sugars and Dicarbonyl Compounds in vivo Factor (MIF): A Critical Neurohumoral Mediator Annals Of The New York Academy Of Sciences 2000, 917: 665-671. [PMID: 11268395](https://pubmed.ncbi.nlm.nih.gov/11268395), [DOI: 10.1111/j.1749-6632.2000.tb05432.x](https://doi.org/10.1111/j.1749-6632.2000.tb05432.x). [Structure of a Advanced Glycation End Product That Is Immunologically Cross-Reactive with Its Naturally Occurring Counterparts ](http://www.ncbi.nlm.nih.gov/pubmed/10639083)Al-Abed Y, Bucala R. Structure of a Synthetic Glucose Derived Advanced Glycation End Product That Is Immunologically Cross-Reactive with Its Naturally [PMID: 10639083](https://pubmed.ncbi.nlm.nih.gov/10639083), R. Peripheral blood fibrocytes with proinflammatory function and regulation by glucocorticoids](http://www.ncbi.nlm.nih.gov/pubmed/10446857)Leech M, Metz C, Hall P, Hutchinson P, Gianis K, Smith M, Weedon H, Holdsworth S, Bucala E. factor in rheumatoid arthritis: Evidence of proinflammatory function and of Methylglyoxal by the Nucleophilic Migration (MIF) ROLE IN CELL PROLIFERATION AND GLUCOCORTICOID ACTION*](http://www.ncbi.nlm.nih.gov/pubmed/10364264)Mitchell R, Metz C, Peng T, Migration (MIF) REGULATORY ROLE IN CELL PROLIFERATION AND GLUCOCORTICOID ACTION* Journal M, Bucala R, Al-Abed Y. A Polyhydroxylated AU-rich instability element: Role in tumor cell glycolysis and the Warburg effect](http://www.ncbi.nlm.nih.gov/pubmed/10077634)Chesney J, Mitchell R, Benigni F, Bacher M, Spiegel L, Al-Abed Y, Han J, Metz C, Bucala R. An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: Role in tumor cell glycolysis and the Warburg effect Proceedings Of The National Academy Of Sciences Of The United States Of America in the cardioprotective effect of ethanol](http://www.ncbi.nlm.nih.gov/pubmed/10051651)Al-Abed Y, Mitsuhashi T, Li H, Lawson J, FitzGerald G, Founds H, Donnelly T, Cerami A, Ulrich P, Bucala R. Inhibition of advanced glycation endproduct formation by acetaldehyde: Role in the cardioprotective effect of ethanol Proceedings Of The National Academy Of Sciences Of The United States Of America in Angiogenesis and the Growth of a Murine Lymphoma](http://www.ncbi.nlm.nih.gov/pubmed/10404515)Chesney J, Metz C, Bacher M, Peng T, Meinhardt A, Bucala R. An Essential Role for Macrophage Migration Inhibitory Factor (MIF) in Angiogenesis and the Growth of a with the Potential for Connective Tissue Targeting](http://www.ncbi.nlm.nih.gov/pubmed/10072447)Grab D, Lanners H, Martin L, Chesney J, Cai C, Adkisson H, Bucala R. Interaction of Borrelia burgdorferi with Peripheral Blood Fibrocytes, Antigen-Presenting Cells with the Potential for Connective Tissue Targeting MIF in the control of insulin secretion during stress](http://www.ncbi.nlm.nih.gov/pubmed/10398546)Waeber G, Calandra T, Bonny C, Bucala R. A role for the endocrine and proinflammatory mediator MIF in the control of insulin secretion during stress Diabetes/Metabolism migration inhibitory factor.](http://www.ncbi.nlm.nih.gov/pubmed/9826378)Pastrana S, Metz C, Bucala R, Schleimer R, Bickel C, Scott A. Filarial nematode parasites secrete a homologue of the human cytokine macrophage migration inhibitory is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria](http://www.ncbi.nlm.nih.gov/pubmed/9736745)Calandra T, Spiegel L, Metz C, Bucala R. Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria Proceedings Of The National Academy Of Sciences Of The United States Of America in the Lenses and Blood Vessels of Cigarette Smokers](http://www.ncbi.nlm.nih.gov/pubmed/9848076)Nicholl I, Stitt A, Moore J, Ritchie A, Archer D, Bucala R. Increased Levels of Advanced Glycation Endproducts in the Lenses and Blood Vessels of Cigarette Smokers Molecular Medicine 1998, 4: 594-601. the Adult Rat Testis: Examination of the of the Seminiferous R, Wreford N, Lan H, Atkins R, Hedger M. Local Regulation of Macrophage Subsets in the Adult Rat Testis: Examination of the Roles of the Seminiferous Tubules, Testosterone, and Macrophage-Migration of (CMG) as a guanine advanced glycation end product density lipoprotein receptor-binding site are modified by advanced glycation end products](http://www.ncbi.nlm.nih.gov/pubmed/9636203)Wang X, Bucala R, Milne R. Epitopes close to the apolipoprotein B low density lipoprotein receptor-binding site are modified by advanced glycation end products Proceedings Of The National Academy Of Sciences Of The United States Of America Macrophage Migration Inhibitory Factor (MIF): Role of MIF in Regulating Glucocorticoid Production](http://www.ncbi.nlm.nih.gov/pubmed/10780884)Yang N, Nikolic-Paterson D, Ng W, Metz C, Bacher M, Meinhardt A, Bucala R, Atkins R, Lan H. Reversal of Established Rat Crescentic Glomerulonephritis by Blockade of Macrophage Migration Inhibitory Factor (MIF): Potential Role of MIF in Regulating Glucocorticoid M, Keough K, Kim I, Bucala R, Adamis A. Advanced Glycation End Products Increase Retinal Vascular Endothelial Growth Factor Expression. 1998, 18: 491. [DOI: 10.1097/00006982-199805000-00030](https://doi.org/10.1097/00006982-199805000-00030). - Leech M, Metz Santos L, Peng T, Holdsworth S, Bucala R, Morand E. Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis Arthritis & Rheumatism 1998, Inhibitory Factor (MIF) Annals Of The New York Lateral Wang Motoneurons in Familial and F, Mu W, Metz C, Chesney J, Gemsa D, Donnelly T, Atkins R, Bucala R. MIF Expression in the Rat Brain: Implications for Neuronal Function Dubrovsky L, Mitchell R, Rich D, Ulrich P, Bucala R, Cerami A, Bukrinsky M. Role of cyclophilin A in the uptake of HIV-1 by macrophages and T lymphocytes Proceedings Of The National Academy Of Sciences Of The United States Of America factor: biological and structural features](http://www.ncbi.nlm.nih.gov/pubmed/9535548)Bernhagen J, Calandra T, Bucala R. Regulation of the immune response by macrophage migration inhibitory factor: biological and structural features Journal 151-161. [PMID: 24 Macrophage Migration Inhibitory Factor (MIF): A Critical Upstream Regulator of Acute and Chronic Inflammatory Responses](https://doi.org/10.1016/s0065-7743(08)61089-1)Rice G, Liittschwager K, Metz C, Bucala R. Chapter 24 Macrophage Migration Inhibitory Factor (MIF): A Critical Upstream Regulator of Acute and Chronic Inflammatory Responses 1998, 33: 243-252. [DOI: 10.1016/s0065-7743(08)61089-1](https://doi.org/10.1016/s0065-7743(08)61089-1). - Kapurniotu A, Bernhagen Y, Teichberg S, Frank R, Voelter W, Bucala R. Contribution of advanced glycosylation to the amyloidogenicity of Cooper M, Jerums G. Aminoguanidine has an anti-atherogenic A, Al-Abed Y, Vlassara H, Bucala R, Cerami A. Tobacco smoke is a source of toxic reactive glycation products Proceedings Of The National Academy Of Sciences Of The United States Of America Migration Inhibitory Factor ](http://www.ncbi.nlm.nih.gov/pubmed/9398265)Bendrat K, Al-Abed Callaway T, Metz C, Bucala R. Biochemical and Mutational Investigations the circulating glycation derivatives in uremia](http://www.ncbi.nlm.nih.gov/pubmed/9407512)Fishbane S, Bucala R, Pereira B, Founds H, Vlassara H. Reduction of plasma apolipoprotein-B by effective removal of circulating glycation derivatives in Advanced Glycation Endproduct Modified-DNA (AGE-DNA)](http://www.ncbi.nlm.nih.gov/pubmed/9407550)Pushkarsky T, Rourke L, Spiegel L, Seldin M, Bucala R. Molecular Characterization of a Mouse Genomic Element Mobilized by Advanced Glycation Endproduct glucocorticoid activity with a critical role in inflammatory disease](http://www.ncbi.nlm.nih.gov/pubmed/9430786)Donnelly S, Bucala R. Macrophage migration inhibitory factor: a regulator of glucocorticoid activity with a critical role in inflammatory disease Trends In Molecular Medicine 1997, 3: Atherosclerosis: Relationship to Tissue AGEs](http://www.ncbi.nlm.nih.gov/pubmed/9323713)Stitt A, He C, Friedman S, Scher L, Rossi P, Ong L, Founds H, Li Y, Bucala R, Vlassara H. Elevated in Sera of Euglycemic, Normolipidemic Patients with Atherosclerosis: Relationship to Tissue 9323713](https://pubmed.ncbi.nlm.nih.gov/9323713), [PMCID: PMC2230092](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2230092), (MIF) C, de Kretser D, Bucala R, Hedger M. A switch in the cellular localization of macrophage migration inhibitory factor (MIF) in rat testis after Fatty Acid Oxidation Products by potent antigen-presenting cell capable of priming naive T cells in situ](http://www.ncbi.nlm.nih.gov/pubmed/9177213)Chesney J, Bacher M, Bender A, Bucala R. The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ Proceedings Of The National Academy Of Sciences Of The United States Of America risk factor in diabetic nephropathy](http://www.ncbi.nlm.nih.gov/pubmed/9177242)Koschinsky T, He C, Mitsuhashi T, Bucala R, Liu C, Buenting C, Heitmann K, Vlassara H. Orally absorbed reactive glycation products (glycotoxins): An environmental risk factor in diabetic nephropathy Proceedings Of The National Academy Of Sciences Of The United States Of America migration A, M, Metz C, Nicod P, Bucala R. Insulin secretion is regulated by the glucose-dependent production of islet cell macrophage migration inhibitory factor Proceedings Of The National Academy Of Sciences Of The United States Of America Factor in Immunologically Induced Kidney Disease in the Rat](http://www.ncbi.nlm.nih.gov/pubmed/9126926)Lan H, Bacher M, Yang N, Mu W, Nikolic-Paterson D, Metz C, Meinhardt A, Bucala R, Atkins R. The Pathogenic Role of Macrophage Migration Inhibitory Factor in Immunologically Induced Kidney Disease in the Rat Journal Of Experimental 1997, and Advanced Glycation: Promotion, Progression, and Preventiona Annals Of The New York Academy Of Sciences 1997, 811: 115-129. [PMID: 9186590](https://pubmed.ncbi.nlm.nih.gov/9186590), [DOI: 10.1111/j.1749-6632.1997.tb51994.x](https://doi.org/10.1111/j.1749-6632.1997.tb51994.x). - Donnelly S, Haslett C, Reid P, Grant I, Wallace W, Metz C, Bruce L, Bucala R. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome Nature Medicine 1997, 3: 320-323. [PMID: 9055860](https://pubmed.ncbi.nlm.nih.gov/9055860), [DOI: 10.1038/nm0397-320](https://doi.org/10.1038/nm0397-320). - Lan H, Yang N, Metz C, Mu W, Song Q, Nikolic-Paterson D, Bacher M, Bucala R, Atkins R. TNF- Up-regulates Renal MIF Expression in Endproducts (AGEs): Role Inhibitory Factor (MIF): A Glucocorticoid Counter-Regulator within the of Macrophage Migration Inhibitory Factor in the Regulation of the MIF rediscovered: cytokine, pituitary hormone, and glucocorticoidinduced regulator S, NIKOLICPATERSON BUCALA R, - Bucala R. Lipid and lipoprotein oxidation: basic mechanisms and unresolved questions in 2: 291-307. [PMID: 27406410](https://pubmed.ncbi.nlm.nih.gov/27406410), characterization of structure, backbone and glutathione binding of the human macrophage migration inhibitory factor (MIF)](http://www.ncbi.nlm.nih.gov/pubmed/8897610)M\u00fchlhahn P, Czisch M, Georgescu J, Renner C, Ross A, Holak T, Bernhagen J, Bucala R. NMR characterization of structure, backbone dynamics, and glutathione binding of the human macrophage migration inhibitory factor Mattiace L, Bucala R, Vlassara H. Glycation and microglial reaction in lesions of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment](http://www.ncbi.nlm.nih.gov/pubmed/8840295)Soulis T, Cooper M, Vranes D, Bucala R, Jerums G. Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment Kidney International 1996, 50: 627-634. modifications of N-boc-arginine and N-CBZ-lysine by methylglyoxal Progress in Role of Advanced Glycation End Product Receptors](http://www.ncbi.nlm.nih.gov/pubmed/8674896)Vlassara H, Bucala R. Recent Progress in Advanced Glycation and Diabetic Vascular Disease: Role of Advanced Glycation s65-s66. [PMID: 8674896](https://pubmed.ncbi.nlm.nih.gov/8674896), 10.2337/diab.45.3.s65](https://doi.org/10.2337/diab.45.3.s65). A, Bernhagen J, Teichberg S, Basgen J, Wagle D, Shih D, Terlecky I, Bucala R, A, J, Ulrich P. An agent cleaving glucose-derived protein crosslinks regulator of W. Hydroxyalkenal Formation Induced by Advanced Glycosylation of Low Density Lipoprotein () Journal [DOI: 10.1074/jbc.271.6.2892](https://doi.org/10.1074/jbc.271.6.2892). - the effect of hyperglycemia on atherogenesis and can it be reversed by aminoguanidine? Diabetes Research And Clinical Practice 1996, 30: s157-s159. [DOI: 10.1016/s0168-8227(96)80061-1](https://doi.org/10.1016/s0168-8227(96)80061-1). - Sun H, Swope S, Bernhagen J, Bucala R, Lolis E. The subunit structure of human macrophage migration inhibitory factor: evidence for a trimer Protein Inhibitory Factor (MIF) [DOI: the effect of hyperglycemia on atherogenesis and can it be reversed by aminoguanidine? Diabetes Research And Clinical Practice 1996, implications for lipoprotein clearance and atherogenesis](http://www.ncbi.nlm.nih.gov/pubmed/9044301)Bucala R. Site-specific modification of apolipoprotein B by advanced glycosylation end-products: implications for lipoprotein H, Koike T. The role advanced glycosylation end-products in the E, Bucala R. Model studies of the maillard reaction of Arg-Lys with D-ribose Bioorganic & Medicinal Chemistry 1995, 5: [DOI: 10.1016/0960-894x(95)00513-s](https://doi.org/10.1016/0960-894x(95)00513-s). - Bucala R, Vlassara H. Advanced glycosylation end products in diabetic renal and vascular disease American Journal Of Kidney Diseases 1995, 7503061](https://pubmed.ncbi.nlm.nih.gov/7503061), [DOI: 10.1016/0272-6386(95)90051-9](https://doi.org/10.1016/0272-6386(95)90051-9). Tracey K, W, Manogue K, the and Cells the Gland](http://www.ncbi.nlm.nih.gov/pubmed/8612200)Nishino Shiiki Calandra of Macrophage Migration Inhibitory Factor (MIF) to Secretory Granules within the Corticotrophic and Thyrotrophic Cells of the during the Maillard reaction](https://doi.org/10.1016/0960-894x(95)00375-4)Al-Abed Y, Bucala R. N-carboxymethyllysine formation by direct addition of glyoxal to lysine during the Maillard reaction Bioorganic & Medicinal Chemistry Letters 1995, 5: 2161-2162. [DOI: 10.1016/0960-894x(95)00375-4](https://doi.org/10.1016/0960-894x(95)00375-4). - Calandra T, Bernhagen J, Metz Bacher M, Donnelly T, Cerami A, Bucala R. MIF as end products precedes and correlates with early manifestations of renal and retinal disease in diabetes](https://doi.org/10.2337/diabetes.44.7.824)Beisswenger P, Makita Z, Curphey T, Moore L, Jean S, Brinck-Johnsen T, Bucala R, Vlassara H. Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes Diabetes 1995, 44: 824-829. [DOI: 10.2337/diabetes.44.7.824](https://doi.org/10.2337/diabetes.44.7.824). [Formation of Immunochemical Advanced Glycosylation End Products Precedes and Correlates With Early Manifestations of Renal and Retinal Disease in Diabetes](http://www.ncbi.nlm.nih.gov/pubmed/7789650)Beisswenger P, Makita Z, Curphey T, Moore L, Jean S, Brinck-Johnsen T, Bucala R, Vlassara H. Formation of Immunochemical Advanced Glycosylation End Products Precedes and Correlates With Early Manifestations of Renal and Retinal Disease in Diabetes Diabetes 1995, 44: 824-829. [PMID: 7789650](https://pubmed.ncbi.nlm.nih.gov/7789650), [DOI: 10.2337/diab.44.7.824](https://doi.org/10.2337/diab.44.7.824). [Identification of of Apolipoprotein B Modification by Advanced Glycosylation End Products Blocking Uptake by the Low Density Lipoprotein Receptor *](http://www.ncbi.nlm.nih.gov/pubmed/7738020)Bucala R, Mitchell R, Arnold K, Innerarity T, Vlassara H, Cerami A. Identification of the Major Site of Apolipoprotein B Modification by Advanced Glycosylation End Products Blocking Uptake by the Low Density Lipoprotein Receptor * Journal Of Biological Chemistry 1995, 270: 7738020](https://pubmed.ncbi.nlm.nih.gov/7738020), [DOI: 10.1074/jbc.270.18.10828](https://doi.org/10.1074/jbc.270.18.10828). within the vascular lesions and glomeruli in diabetic nephropathy](http://www.ncbi.nlm.nih.gov/pubmed/7890283)Nishino T, Horii Y, Shiiki H, Yamamoto H, Makita Z, Bucala R, Dohi K. Immunohistochemical detection of advanced glycosylation end products within the vascular lesions and glomeruli in diabetic nephropathy Prevents Acute Inflammation and Endotoxin Lethality](http://www.ncbi.nlm.nih.gov/pubmed/8529104)Bianchi M, Ulrich P, Bloom O, Meistrell M, Zimmerman G, Schmidtmayerova H, Bukrinsky M, Donnelley T, Bucala R, Sherry B, K, A, K. An Macrophage Arginine Transport and Nitric Oxide Production (CNI-1493) Prevents Acute Inflammation and Endotoxin DeSimone C, Cerami A, Bucala R. A role for DNA mutations in diabetes-associated teratogenesis in transgenic embryos Diabetes 1995, [DOI: 10.1007/978-94-011-1468-4_260](https://doi.org/10.1007/978-94-011-1468-4_260). macrophage migration inhibitory factor](https://doi.org/10.1007/978-94-011-1468-4_393)Kaiser T, Bernhagen J, Bucala R, Paulus G, Voelter W. Different approaches for solid phase peptide synthesis of mouse macrophage migration inhibitory factor 1995, 853-854. [DOI: 10.1007/978-94-011-1468-4_393](https://doi.org/10.1007/978-94-011-1468-4_393). - Bucala R, Cerami A. Glucose Significance, and Prospects for Pharmacological Inhibition](http://www.ncbi.nlm.nih.gov/pubmed/7619388)Bucala R, Vlassara H. Advanced Glycosylation Endproducts in Diabetic Renal Disease: Clinical Measurement, Pathophysiological Significance, and Prospects for 160-170. DeSimone C, Cerami A, Bucala R. A Role for DNA Mutations in Diabetes-Associated Teratogenesis in Transgenic macrophage cytokine and its role in endotoxic shock](http://www.ncbi.nlm.nih.gov/pubmed/7737686)Bucala R. Identification of MIF as a new pituitary hormone and macrophage cytokine and its role J, Hogan M, Cerami A. Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue endproducts (AGE-LDL) lies within a 28-kDa region located N-terminal to the LDL-receptor binding domain](https://doi.org/10.1016/0021-9150(94)93201-8)Bucala R, Mitchell R, Vlassara H, Cerami A. The primary site of apolipoprotein-B modification by advanced glycosylation endproducts (AGE-LDL) lies within a 28-kDa region located N-terminal LDL-receptor binding domain Cerami A, Bucala R. MIF IS AN IMPORTANT MEDIATOR OF THE TOXIC SHOCK SYNDROME. Shock 1994, 2: 16. [DOI: 10.1097/00024382-199409001-00007](https://doi.org/10.1097/00024382-199409001-00007). - Al-Abed Y, Voelter W, Cerami A, Bucala R. Identification of 4-hydroxyhexenal as an oxidation product formed LDL endproducts: Role in diabetic and nondiabetic disease 1994, migration inhibitory factor is a neuroendocrine mediator of endotoxaemia In 1994, - Bernhagen R. The emerging role of MIF in septic shock infection Biotherapy 1994, Cerami A, Bucala R. Comparative analysis of DNA mutations in lacI transgenic mice with age The FASEB Journal 1994, 8: 545-550. and GRO by synovial fibroblasts in chronic arthritis: Possible role in growth regulation](http://www.ncbi.nlm.nih.gov/pubmed/8003635)Hogan M, Sherry B, Ritchlin C, Fabre M, Winchester R, Cerami A, Bucala R. Differential expression of the small inducible cytokines GRO and GRO by synovial fibroblasts in chronic arthritis: Possible role E, Rodby R, Cerami A, Bucala R. Hemoglobin-AGE: A Circulating Advanced Glycosylation: Chemistry, Biology, and Implications for Diabetes and Aging 1992, 1-34. Wang P, Rutherford J. Labile T-wave changes caused by respiratory variation in a patient with unstable angina International Journal Of of lysine adducts with 16-hydroxyestrone and cortisol The Journal Of Fishman J. Determination of 16 alphahydroxyestrone by radioimmunoassay in systemic and glucocorticoid toxicity](http://www.ncbi.nlm.nih.gov/pubmed/3842583)Bucala modification Pathological implications Cerami A. Glucocorticoid-lens protein adducts in experimentally induced steroid cataracts 1985, 40: 853-863. [PMID: 4018168](https://pubmed.ncbi.nlm.nih.gov/4018168), [DOI: 10.1016/0014-4835(85)90130-7](https://doi.org/10.1016/0014-4835(85)90130-7). [Increased levels pregnancy and in systemic lupus erythematosus.](http://www.ncbi.nlm.nih.gov/pubmed/3920233)BUCALA R, LAHITA R, FISHMAN J, CERAMI A. Increased levels of 16 alpha-hydroxyestrone-modified proteins in pregnancy and in systemic lupus erythematosus. The Journal Of Clinical BRADLOW H, FISHMAN J. Role of Sex Steroids in Systemic Lupus Erythematosus (SLE) 1985, 33: and aggregate formation: In vitro and in vivo studies](http://www.ncbi.nlm.nih.gov/pubmed/4065253)Bucala R, Manabe S, Urban R, Cerami A. of lens crystallins by prednisolone induces sulfhydryl oxidation and aggregate formation: In vitro and in vivo Eye 41: 353-363. 10.1016/s0014-4835(85)80026-9](https://doi.org/10.1016/s0014-4835(85)80026-9). - A. The reaction of 16hydroxyestrone with erythrocytes in vitro and in formed by the nonenzymatic reaction of 16-hydroxyestrone with albumin](http://www.ncbi.nlm.nih.gov/pubmed/6656775)Bucala R, Cerami A. Characterization of antisera to the addition product formed by the nonenzymatic reaction of 16-hydroxyestrone of a Perfluorocarbon Blood Substitute "}